A prospective study on injection tramadol hydrochloride as a labour analgesic and its effect on duration of labour by Vaishnavi, V S
A PROSPECTIVE STUDY ON INJECTION TRAMADOL 
HYDROCHLORIDE AS A LABOUR ANALGESIC AND 
ITS EFFECT ON DURATION OF LABOUR 
Dissertation submitted 
 in partial fulfillment of requirements for 
 
M.S. DEGREE BRANCH II 
 
OBSTETRICS AND GYNAECOLOGY 
MADRAS MEDICAL COLLEGE 
CHENNAI 
 
 
 
 
 
 
 
THE TAMIL NADU DR. M.G.R. MEDICAL       
UNIVERSITY, CHENNAI 
APRIL 2013 
CERTIFICATE 
 
This is to certify that the dissertation entitled “A PROSPECTIVE 
STUDY ON INJECTION TRAMADOL HYDROCHLORIDE AS A 
LABOUR ANALGESIC AND ITS EFFECT ON DURATION OF 
LABOUR” is a bonafide work done by DR.V.S. VAISHNAVI in the 
Institute of Obstetrics and Gynaecology (Madras Medical College)  
Egmore,  Chennai  in  partial  fulfillment  of  the  university rules  and 
regulations for award of MS degree in Obstetrics and  Gynaecology 
under my guidance and supervision during the academic year 2011-2013.
  
 
 
Prof.DR.V.KANAGASABAI,M.D.,   Prof. DR. P.MEENALOCHANI,M.D.,DGO.,  
Dean,             Director and Superintendent, 
Madras Medical College &   Institute of Obstetrics & Gynaecology 
Rajiv Gandhi Govt. General Hospital  Madras Medical College, 
Chennai – 3     Chennai – 3 
      
 
 
 
Prof.DR.P.MEENALOCHANI MD. DGO 
Guide, Director and Superintendent, 
Institute of Obstetrics and Gynaecology 
Madras Medical College, 
Chennai – 3 
  
DECLARATION 
 I hereby declare that the study titled “A PROSPECTIVE STUDY 
ON INJECTION TRAMADOL HYDROCHLORIDE AS A 
LABOUR ANALGESIC AND ITS EFFECT ON DURATION OF 
LABOUR” was done by me in the Institute of Obstetrics and 
Gynaecology (IOG), Madras Medical College, Chennai – 600 003, 
during the period of my PG study for  M.S Obstetrics and Gynaecology 
from 2011-2013, under the guidance and supervision of,       
Prof.Dr. P.MEENALOCHANI M.D., DGO. 
This dissertation is submitted to the TamilNadu Dr. M.G.R. 
Medical University, Chennai in partial fulfillment of University 
regulations for the award of  M.S. Degree Examination in Obstetrics and 
Gynaecology.    
 
Signature of Candidate  
Prof.DR.P.MEENALOCHANI,MD.,DGO., DR. V.S. VAISHNAVI., 
Guide, Director and Superintendent,  M.S., P.G (Obsetrics and Gynaecology) 
Institute of Obstetrics and Gynaecology Institute of Obsetrics and Gynaecology 
Madras Medical College,   Madras Medical College, 
Chennai – 3     Chennai -3. 
ACKNOWLEDGEMENT 
I gratefully acknowledge and sincerely thank  
Prof.Dr.V.KANAGASABAI, M.D, DEAN, Madras Medical College and 
Rajiv Gandhi Govt.General  Hospital, Chennai 600003 for permitting 
me to conduct the study and use the facilities of the Institution for my 
study. 
I am  grateful  to  the  Director  and  Superintendent,  
Prof.Dr.P.MEENALOCHANI, M.D.,DGO,  Institute  of  Obstetrics &  
Gynaecology,  Egmore,Chennai,  for her valuable guidance and 
supervision throughout my study.. 
I am extremely thankful to our Deputy Superintendent,            
Prof. Dr. RUKKMANI, M.D., D.G.O., for her support in conducting 
this study. 
Dr. JAYA, M.D., D.G.O., Former Director and Superintendent, 
Institute of Obstetrics and Gynaecology, Egmore for granting me 
permission to utilize the facilities of the institute for my study. 
I wish to express my deep sense of gratitude to 
Prof.Dr.D.TAMILSELVI, M.D., D.G.O., for her valuable guidance.  
I am thankful to the RMO and all UNIT CHIEFS for their support, 
advice and encouragement. 
 My special thanks to Dr. RAJENDRAN M.D, DA, Head of the 
Department of anaesthesiology for his co-operation and help for 
conducting this study. 
I am thankful to all Assistant Professors and Teachers for their 
guidance and help. 
I thank my husband and my family members for their constant 
encouragement and moral support throughout this study. 
Last, but not the least, I thank all my patients for their kind co-
operation who made this study feasible. 
 
CONTENTS 
S.NO CONTENTS PAGE NO. 
1. INTRODUCTION 1 
2. AIM OF THE STUDY 4 
3. REVIEW OF LITERATURE 5 
4 MATERIALS AND METHODS 53 
5. OBSERVATION & RESULTS 57 
6. DISCUSSION 76 
7. SUMMARY 84 
8. CONCLUSION 86 
9. BIBLIOGRAPHY  
10. ANNEXURE  
 PROFORMA 
MASTER CHART 
ETHICAL COMMITTEE 
CERTIFICATION 
 
1 
 
INTRODUCTION 
“The Delivery of the infant into the arms of a conscious and pain 
free mother is one of the most exciting and rewarding moments in 
medicine” - Moir 1 
 Pain is the single most sentinel for the beginning of labor. The pain 
of labour is unique in that it is a normal physiological process.  Labour 
may be the most painful experience many women may encounter. 
Pain relief in labour has always been surrounded with myths and 
controversies. Hence providing effective and safe analgesia during labour 
has remained as an on going challenge. 
“For all happiness mankind can gain is not in pleasure but in rest from 
pain” – John Dryden. 
 Read (1944) has emphasised that the intensity of pain during 
labour is related in large measure to emotional tension. 
 Pain and agony during childbirth is acute often unbearable and at 
times beyond description.  In painful labour there is  25% reduction in the 
uteroplacental blood flow.  Effective analgesia prevents the pain induced 
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hyperventilation and hypocapnia which can be severe enough to produce 
tetany in painful labour. 
Adequate analgesia during labour is of benefit to the mother and 
has a positive influence on the course of labor and the state of newborn 
child, thus making obstetrical analgesia an essential part of modern 
obstetrics. 
 The American college of Obstetricians and Gynaecologists (2002) 
has stated that a “woman’s request for labor pain relief is sufficient 
medical indication for its provision”.2 
 Adequate analgesia during labor is beneficial to the mother and has 
a positive influence on the course of labor and the newborn child.  The 
experience of labourpain is modified by emotional, motivational 
cognitive, cultural and social circumstances.  Choice among a variety of 
methods and individualization of pain relief is describable. 
 An ideal analgesic should be  easy to administer, should not affect 
the consciousness level of the parturient,provide reversible, predictable 
and good analgesia. It should allow the parturient to ambulate at least 
during early stages of labour and not interfere with uterine contractions.  
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It should not be toxic to mother and fetus and not produce 
cardiorespriratory depression in the foetus.3 
 Tramadol  is a weak opioid agent, which has an analogous 
analgesic efficacy to meperidine (pethidine).  It causes less neonatal 
respiratory depression and less sedative effect. 
 In the present study, the efficacy of intramuscular tramadol 
hydrochloride as a  labour analgesic and its effect on the duration of 
labour and its effect on the  mother and newborn were studied. 
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AIM OF THE STUDY 
1. To study the effect of intramuscular tramadol hydrochloride for 
pain relief in labour in primigravid patients. 
2. To study the effect of the drug on duration of labour. 
3. To study effect of the drug on the mother and newborn. 
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REVIEW OF LITERATURE 
 “The experience of  labour pain is a highly individual reflection of 
variable stimuli that are uniquely  received and interpreted by each 
woman” – Lowe (2002)2 
 Melzack determined that about 60-80% of   parturients   rated their 
labour pain as severe in nature while about 23% of primipara and 11% of 
multipare rated their pain as horrible.5 
 Babyloneans were the first to use various methods for pain control 
in labour. Opioids were used 5500 years ago.  Early days, in the 
mythology of china, Egypt, Greece and troy, concoctions, decoctions, 
herb extracts or wines were used, for relief of labour pain.  Physical 
methods like jumping over mother’s abdomen to hasten delivery were 
used.  Psychological methods using hymns, rings, talisman and hypnosis 
were tried. 
 Alcohol was kept beside maternity bed for self administration 
according to the persons.  Morphine was used which though was useful 
in labour pain relief caused foetal distress. 
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 January 19, 1847, James young Simpson, a Scottish obstetrician 
used ether for a woman with deformed rickety pelvis during childbirth. 
Charles D Meigs, a Philadelphian obstetrician criticised this and 
hypothesized the concept of ‘no drug labour’. Simpson proposed that 
“medical men may oppose for a time the super induction of anaesthesia 
in parturition, but they will oppose it in vain, for certainly our patients 
themselves will force use of it upon the profession”.6 
 John Snow in 1853, administered chloroform to the Britain Queen 
Victoria for the birth of her eighth child, Prince Leopold.  This method  
‘Narcose a la reine’ received warm approval from the queen.  
 Emil fischer and Vommering introduced Barbiturate in 1908. 
Phenobarbitone was used in 1912. Pethidine was used since 1940. It was 
used by 68.9% of laboring women by 1970, but has been superseded by 
other agents now. Clark in 1971, first used the opioid antagonist, 
naloxone. 
 Regarding regional techniques, the first pudendal block was given 
by Dr. Mueller. First paracervical block was given by Gelut in 1926. In 
1927, Dellapiane used the first lumbar sympathetic block. In 1935, the 
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first epidural block was performed by Graffignino. First continuous 
epidural analysia was given by Flower et al in 1946. 
NORMAL LABOUR 
 It is the spontaneous onset of regular painful uterine contractions 
associated with effacement and dilatation of the cervix and descent of the 
presenting part, with or without a show or ruptured membranes. This 
process culminates in the birth of a healthy baby followed by expulsion 
of the placenta and membranes.   
PAIN IN PARTURITION 
Pain is a word for which it is difficult to find a satisfactory 
definition. Beecher has proposed that pain can be divided into two 
components. The first part is the original pain sensation (i.e; the sensory 
aspect). The second part is the behavior response to pain (i.e; the motor 
aspect). Pain threshold is the level at which discomfort reaches sufficient 
intensity to be interpreted by the subject as a painful sensation. This 
sensory appreciation of pain can be slightly altered by various factors 
such as fatigue and distraction. The pain threshold varies in the same 
person from time to time and differs in different individuals. Sensory 
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pain also has the quantitative property of intensity or amount and 
severity. The amount of pain experienced in labour has never been 
proved to be related to the general pain threshold of the individual. 
The motor component or reaction to pain by the patient can be 
modified by many influences. Personality and cultural background and 
drugs are examples of these factors. There is no correlation between the 
amount of pain that a patient experiences and her reaction to it.7 
Melzack using the multidimensional Mc gill pain questionare 
found  that the total pain rating index (PRI) was 34% for primi and 30% 
for multiparas.5 
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MECHANISM OF THE PAIN OF LABOUR 
First Stage of Labour:  
Pain in the first stage of labour arises from the uterus and adnexae 
during contraction and is visceral in nature. Pain is largely due to the 
formation of lower uterine segment (LUS) and cervical dilatation with 
subsequent mechanical distention, stretching and tearing during 
contraction. Chemical nociception mediators contribute to pain including 
bradykinin, substance P, leukotrienes, lactic acid, prostaglandin,5 
hydroxy tryptamine.  
  
  
 
 
 
 
 
 
Figure-1: Relation between duration of uterine contraction and duration 
of pain associated with the contraction
must     reach 
lag of 20 seconds during the
labour when the buildup of the contraction is slower. As labour 
progresses, the contraction reaches its p
the lag is 
 
Hypothesis of Uterine Nociception Origin: 
Time of onset of uterine contractions is related to time of onset of pain
(figure-1). The observed lag time between t
needed for a contraction to generate an increase in amniotic fluid pressure 
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. Intensity of contraction 
25 mm Hg before pain is perceived and
 early phase of the first stage of 
eak more rapidly and 
shortened.9  
 
he two reflects the time 
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11 
 
to 15 mm Hg above baseline. To initiate cervical dilatation 
typically,intrauterine pressure must exceed 25 mm Hg before pain is 
experienced.10 During early labour less than 45% of contraction time is 
associated with pain, whereas during late first stage 60% of contraction 
time is associated with pain. The unanesthetized uterus can be incised 
and gently palpated without discomfort to the patient undergoing 
cesarean delivery under abdominal field block, whereas forceful 
palpation and stretching of the cervix and lower uterine segment under 
the  same conditions provide pain similar in quality and location to that 
occurring during labour. Though the postpartum uterine contractions are 
2-3times greater in  magnitude the intensity is less.11  
 
Second Stage of Labour:  
Afferent transmission from the vagina and pelvic outlet is via Aδ 
and C fibres, but with the parasympathetic bundle in the pudendal nerves 
(S2,S3,S4).There is also a minor contribution from the ilioinguinal, 
genitofemoral and the perforating branch of the posterior cutaneous nerve 
of thigh. It is important to appreciate that pain-sensitive structures in the 
pelvis are also involved, that is, the adnexae, the pelvic parietal 
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peritoneum, bladder, urethra, rectum and roots of the lumbar plexus. 
Therefore, the second stage pain is somatic in nature and best relived by a 
local anesthetic. 
NEURAL PATHWAYS OF PARTURITIONAL PAIN 
Head and Cleland concluded that nociceptive impulses from the 
body of the uterus are transmitted through T11 and T12 nerves and the 
pain from the LUS and the cervix is transmitted through the pelvic nerve 
to the S2,S3,S4 spinal segments.  
Parturition pain has two components 
1.Visceral components 
2.Somatic components  
VISCERAL COMPONENT 
From the uterus, the visceral component reaches T10 through L 1 
segments of the spinal cord. Bonica9 demonstrated conclusively that the 
lower uterine segment and upper part of the cervix are in fact supplied by 
afferents that supply the body of the uterus and accompany the 
sympathetic nerves and not by any of the sacral nerves. Parasympathetic 
 innervation of the uterus does not appear to ha
pain mediation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
                         Figure
nociceptive pathways involved in the pain of childbirth
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SOMATIC COMPONENT 
Somatic pain is due to stretching of the perineum. Painful impulses 
are transmitted primarily through pudendal nerve, which is derived from 
anterior division of sacral nerves S 2 -S 4. In addition to innervating the 
vagina, vulva and the perinum, the pudendal nerve supplies motor fibers 
to various skeletal muscles of the pelvic floor and perineum. The 
ilioinguinal nerve and genital branch of the genitofemoral nerve provide 
peripheral innervation of  the perineum anteriorly, the posterior 
cutaneous nerve supplies lateral innervation. 
Following transmission of nociceptive information from the uterus, 
cervix and perineum to the dorsal horn, as with other acute pain states, 
this information is then relayed to other parts of the spinal cord. The 
multidimensional response to pain (sensory, affective and evaluative 
dimension) is determined at higher centers of the brain through 
spinothalamic and other ascending pathways and limbic system.  
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CAUSES OF PAIN DURING LABOUR 
There are a variety of noxious stimuli that lead to the pain of 
labour. They give rise to subjective discomfort, as well as objective 
alterations in cardiorespiratory function and autonomic nervous system. 
 Myometrial hypoxia : Contraction of a muscle  during a period 
of hypoxia causes pain. When uterine relaxation between 
contractions is insufficient to allow adequate oxygenation, the 
severity of the pain is increased. 
 Stretching of the cervix: The pain is mainly felt in the back.  
 Pressure on the nerve ganglia adjacent to the cervix and vagina.  
 Traction on the tubes, ovaries and peritoneum.  
 Traction on and stretching of the supporting ligaments.  
 Pressure on the urethra, bladder and rectum.  
 Distension of the muscles of the pelvic floor and perineum.12 
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EFFECTS OF LABOUR PAIN  
Pain has deleterious effect on both mother and foetus13. The effects 
are mediated at three levels  
• Cortical 
• Suprasegmental  
• Segmental 
CORTICAL  
It is mediated by impulses arriving in the somatosensory cortex 
through neospinothalamic tract. Its effect includes anxiety, fear, 
emotional, arousal, behavior changes like verbalization and motor 
activity. Anxiety itself can produce in-coordinate uterine contraction and 
total depression.  
SUPRASEGMENTAL  
It is mediated by the connections of the paleospinothalamic tract 
with the reticular formation. Its effects include hyperventilation and 
endocrine response increasing the ACTH, cortisol  and aldosterone 
levels. This increases oxygen consumption. They reach a peak at or after 
delivery14. In a study in a group of unpremedicated, unprepared 
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primiparas, ventilation increased from normal mean of 10 litres/minute 
between contractions to a mean 23-35 litres/minute during contraction, 
causing marked increase in tidal volume and minute ventilation.  
SEGMENTAL  
Local neuronal connection at the spinal dermatome is responsible 
for this effect. Its effect includes decreased gastric motility, delayed 
gastric emptying, ileus, nausea and vomiting. 
Clinical Characteristics of Labour and Delivery Pain 
The clinical characteristics of uterine contraction pain (i.e., first 
stage labour pain) are distinct from those associated with delivery pain 
(i.e.,2ndstage labour pain) suggesting use of distinct neural pathways.    
Peripheral visceral afferents branch considerably, overlap at the dorsal 
roots and convey on the dorsal horn over a wide number of segments. 
Hence visceral pain is described clinically as being dull and  vague. It is 
poorly localized. Referred pain during labour is explained partly by the 
convergence of visceral and somatic nociceptive afferents on the same 
dorsal horn neuron. Visceral pain of uterine contractions has a delayed 
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transmission . Aching, cramping, pain during the latent phase of labour is 
referred and   limited to T 11, T 12 dermatomes(lower back). Pain 
becomes severe in active phase of first stage  of labour (cervix dilated 3-4 
cm) with increasing intensity of uterine contraction spreading to involve 
the T 10 and L 1 dermatomes. Low back pain is the result of nociceptive 
transmission in the T 10 -L 1segments. 
 30% of women during the first stage of labour experience severe lumbar 
low back pain which is the result of referred pain via dorsal rami of nerve 
root T 10 -L 1, the lateral branches of which travel caudally before 
becoming superficial and supplying the skin over the lower back and 
posterior pelvic rim. Descent of the fetal presenting part during the late 
first stage and second stage of labour produces sharp, well localized 
somatic pain in the region innervated by the pudendal nerve. Pain is 
perceived most acutely in the lower part of the sacrum, the perineum, 
vagina, rectum and thighs (L 2 to S 1 spinal cord segments). 16 
Pressure on and traction of pain sensitive structures in the pelvic 
cavity including pressure on nerve roots of the lumbosacral plexus, 
stretching of ligaments, fascia, muscles, traction on pelvic parietal 
19 
 
peritoneum and uterine ligaments and tension of the bladder, urethra and 
rectum and it may be referred to the sacral segments and lower lumbar 
segments. 
  
Figure:3: Distribution and intensity of labor pain during each 
stage of labor and delivery 
A – In the early first stage, pain is referred to the T11 and T12 
dermatomes.  
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B – In the late first stage, however, the severe pain is also referred to the 
T10  and L1 dermatomes. 
C – In the early second stage, uterine contractions remain intense and 
produce severe pain in the T10 to L1 dermatomes. At the same time the 
presenting part exerts pressure on pelvic structures and thus causes 
moderate pain in the very low back and perineum and often produces 
mild pain in the thighs and legs. 
D – Intensity and distribution of pain during the late phase of the second 
stage and during actual delivery. The perineal component is the primary 
cause of pain, whereas uterine contractions produce moderate pain15 
Other factors that influence the pain of childbirth include physical, 
psychologic, emotional and motivational, ethnocultural and 
neurohumoral factors. 
Physical Determinants: Factors identified as influencing the degree of 
labour pain experienced by the parturient include her age, parity and 
physical condition and size of the infant in relation to the size of the birth 
canal. Primiparae appear to suffer more pain than multiparous women. 
There appears to be a differential pattern of the progression of labour 
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pain, with nulliparae reporting more pain during early and active labour 
and less pain during second stage than multiparae. It follows that a short 
first stage of labour with rapidly dilating cervix should therefore involve 
more pain than a longer first stage. 
Melzack and associates found that pain scores were  increased in 
heavier women. The heavier the primipara was per unit of height , more 
was the pain score. Position during labour appears to influence the 
amount of pain experienced. Some evidence suggest that women feel less 
pain when their labour and delivery was in an upright position. The 
actual intensity of labour contractions is more important with the 
perception of pain than contraction duration. 
Psychologic consideration 
Psychologic factor include attitude towards labour, fear and 
anxiety, expectations of pain, prior experience of pain and knowledge of 
the process of pregnancy and parturition. A frequent cause of fear and 
anxiety is lack of knowledge of or misinformation about process of 
labour and delivery.  
During the first stage of labour, fear of pain has a high correlation with 
pain levels.In second stage of labour concerns about pain shift to 
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concerns regarding the potential for self injury during birth and the 
neonate’s well being. 
Neurohormonal Factor 
Neurohormonal changes in pregnancy may modify the responses to 
pain. Uterine distention and cervical stretching occurring in later stages 
of pregnancy and parturition result in stimulation of afferent fibres in the 
pelvic and hypogastric nerves activating pregnancy induced hypoalgesia 
via a spinal, probably κ opioid system. 
Dawson Basoa and Gin Tzler indicate that δ opioid receptor 
activity is a prerequisite for the manifestation of a substantial portion of 
gestational and hormone simulated pregnancy analgesia whereas the 
potent spinal µ opioid analgesia system does not participate. Increased 
progesterone during pregnancy is thought to increase sensitivity to 
analgesic agents. 
In addition to the classic opioid receptor (µ,δ,and κ) cloning 
studies have revealed an atypical opioid receptor with 50% homology to 
µ, δ and κ opioid receptor termed ORL (opioid receptor like)- 1 and is 
found in CNS areas involved in pain perception.
 Table-2: Summary 
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of some of the factors that may influence 
the pain of childbirth 
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STAGES OF LABOUR 
  First stage of labour  
Fried man divided labour into 3 functional divisions. 
1. Preparatory Division – during which cervix dilates a little with 
considerable change in its connective tissue components. Sedation 
and conduction analgesia are capable of arresting this division of 
labour. 
2. Dilatation division- during which dilatation is rapid and is 
unaffected by sedation or conduction analgesia. 
3. Pelvic division.  
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Cervical Dilatation is divided into 2 phases. 
1. The latent phase – Corresponds  to the preparation division . 
2. Active phase – Corresponds   to the dilatational division. 
Friedman sub divided this active labour in to acceleration phase, 
phase of maximum slope and deceleration phase. 
 
 The latent phase may last for upto eight hours in nulliparas 
and upto six hours in multiparas. During the peak of the active 
phase of labour, the rate of cervical dilatation is 1 cm per hour in 
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both nullipara and multipara. Descent is expected to occur at the 
rate of 1 cm/hour in primipara and 2 cm/hour in multipara. 
Second Stage of labour 
Begins when cervical dilatation is complete and end with fetal 
delivery. It is divided into two phases 
Phase 1- passive phase (phase of descent, pelvic phase) 
 The passive phase is from full cervical dilatation until the fetal 
head reaches the pelvic floor. Major portion of fetal descent occurs in this 
phase and is highly variable. 
Phase 2 – Active phase (expulsive phase, perineal phase) 
  It is marked by the maternal urge to bear down.  
The median duration is variable. It is approximately 50 minutes in 
primipara and  20  minutes in multipara. The length of second stage 
varies and is influenced by position of the mother, fetus,uterine 
contraction,use of oxytocin, pushing efforts of the women and type of 
analgesia used. 
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Duration of labour 
 The mean length of first & 2nd stage of labour was 9 hours in 
nulliparous women without reginal analgesia and 6 hours in multiparas. 
 ACOG guidelines define “dystocia in nulliparous women as a 
second stage that lasts for more than three hours when regional 
anaesthesia  is used and more than 2 hours when it is not. It is 2 hours 
and 1hour for multiparae”.2  
 
           
 METHODS OF PAIN MEASUREMENT
Patients report of pain is recorded as pain score. The pain score 
used should be valid,
used to measure pain is dolorimeter.
 
 
 
Pain rating index using Mc Gill pain questionnaire
28 
 reliable and geared to the patient. The
17 
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 instrument 
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 WONG BAKER FACES P
Different facial expressions are used to describe the intensity of pain. It is 
specifically used in the paediatric age group.
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AIN RATING SCALE 
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VISUAL ANALOGUE SCALE  
Has a 10 cm line denoting pain intensity by adjectives or number. 
These are graphic rating scales. The patients indicate a point on the line 
depending on its intensity. 18 
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METHODS OF LABOUR ANALGESIA 
NON PHARMACOLOGICAL  
1. Psychoprophylaxis – hypnosis, prepared child birth, breathing 
exercises. 
2.  Modifications of  labour room environment – presence of 
relatives, soothing music, etc. 
3.  Physical modalities – acupunture , massaging heating pads, warm 
bath, and intradermal injection of sterile water. 
4.  Transcutaneous electrical nerve stimulation (TENS) 
PHARMACOLOGICAL  
1. systemic opioids  –    Pethidine i.v / i.m 
                        Tramadol i.m 
                        Fentanyl i.v / i.m 
                        Remifentanil i.v/ i.m 
                                            Pentazocine  
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2. Inhalational agents –  Entonox  - 50% nitrous oxide in 50% oxygen 
( PCIA)       Desflurane 
               Isoflurane 
                     Sevoflurane 
3. Regional analgesia -   Paracervical block 
           Pudendal block 
       Subarachnoid block 
     Continous lumbar epidural analgesia 
 Patient controlled epidural analgesia 
         Combined spinal epidural block 
  Lumbar sympathetic block19 
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SYSTEMIC ANALGESIA   
Systemic drugs have been used to decrease the pain of childbirth. 
 systemic analgesic drugs is used especially in  
1. Some conditions (e.g., hemorrhages, coagulopathy) that 
contraindicate the administration of epidural and spinal 
anesthesia.  
2. Epidural anesthesia is not available in all hospitals 
especially smaller facilities. 
3. Epidural anesthesia is not without risk, and some women 
decline this technique.  
4. Alternatively, some women choose to receive a systemic 
analgesic during early labour and opt for epidural anesthesia 
as pain becomes more intense. 
Parenteral Opioids 
Opioids are the most widely used systemic medications for labour 
analgesia. Use of these drugs does not require the use of specialized 
equipment or personnel. These drugs allow the parturient to better 
tolerate the pain of labour but typically they do not provide complete 
analgesia. Although systemic opioids have long been used for labour 
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analgesia, there is little scientific basis to suggest that one drug is 
intrinsically better than another for this use. Most often the choice of 
opioid is based on institutional condition and  or personal preference. The 
efficacy of analgesia and the incidence of side effects are largely dose 
dependent rather than drug dependent. Because of their lipid solubility 
and low molecular weight (<500 daltons), all opioids easily cross the 
placenta by diffusion and are associated with the risk of neonatal 
respiratory depression and neurobehavioral changes. Neonatal 
metabolism and elimination of drugs are prolonged. There may be subtle 
changes in the neuro behavior of the neonate, the clinical significance of 
which is unclear.  
Modes of Administration:  
Intermittent Bolus Doses:  
Opioids may be given subcutaneously or intramuscularly. More 
often opioids are administered intravenously either intermittently or by 
continuous intravenous infusion. The route and timing of administration 
influence maternal uptake and placental transfer. Subcutaneous and 
intramuscular injections have the advantage of simplicity. Of course 
intramuscular injection is painful. Absorption varies with the site of 
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injection and injection is followed by a delay in the onset of analgesia. 
Subcutaneous or intramuscular injection results in analgesia of variable 
onset, quality and duration. Advantages of intravenous administration 
include (1) less variability in the peak plasma concentration of drug (2) 
faster onset of analgesia (3) the ability to titrate dose to effect.  
Patient Controlled Analgesia (PCA)  
PCA is a cost-effective technique that produces superior analgesia 
with very high patient satisfaction. Patients are able to self administer 
precise dose of drug. Purported advantages of PCA include  
 Superior pain relief with lower doses of drugs.  
 Less risk of maternal respiratory depression (compared with 
bolus intravenous administration). 
 Less placental transfer of drug. 
 Less need for anti-emetics. 
 Higher patient satisfaction.  
PCA for labour is not without limitation despite frequent 
administration, small doses of opioid may not always be effective for the 
fluctuating intensity of labor pain. Also the risk to the fetus and neonate 
remains unclear. PCA can be used if epidural analgesia is unavailable, 
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contradicted or unsuccessful. Although, PCA may result in higher 
patients administration, most studies have not demonstrated either 
reduced use of drug or improved analgesia with PCA when compared 
with IV administration by the obstetric nurse.  
 
CLASSIFICATION OF OPIOID ANALGESICS  
1. Natural opium alkaloid : Morphine, codeine.  
2. Semi-synthetic opiates: Diacetyl morphine (Heroin), Pholcodeine. 
3.  Synthetic opioids : Pethidine (Meperidine), fentanyl, methadone, 
dextropropoxyphene, tramadol, ethoheptazine .21 
 
OPIOID RECEPTORS:  
Morphine and other opioids exert their action by interacting with 
specific receptors present on neurons in the central nervous system and in 
peripheral tissues. Radioligand binding studies have divided the opioid 
receptors into three types: µ,κ,δ  each has a specific pharmacological 
profile and pattern of anatomical distribution in brain,spinal cord and 
peripheral tissues. Subtypes of µ and κ receptor have been identified.
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Actions ascribed to different  types of opioid receptor  
µ(mu)  κ(kappa)  δ(delta)  
Analgesia (supraspinal 
µ 1  
+ spinal µ 2 )  
Analgesia (spinal κ1 )  
(supraspinal κ 3 )  
Analgesia (spinal + 
affective component 
of supraspinal) 
Respiratory depression 
(µ 2 )  
Respiratory depression  
(lower ceiling) 
Respiratory 
depression  
Euphoria  Miosis (lower ceiling) Affective behaviour  
Miosis  Dysphoria  Reinforcing actions  
Reduced GI motility  Hallucinations  Reduced GI motility 
Physical dependence 
(morphine type) 
Physical dependence 
(Nalorphine type) 
 
Sedation   Sedation   
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TRAMADOL HYDROCHLORIDE 
Tramadol hydrochloride is a narcotic drug introduced in 1971 in 
germany and is now available throughout the world. Tramadol 
hydrochloride is a synthetic 4-phenyl-piperidine analogue of 
codeine with a dual mechanism of action.20  
Tramadol hydrochloride is a centrally acting synthetic 
codeine analogue that is a weak opioid receptor agonist. Its affinity 
for µ opioid receptor is modest while that for κ and δ is weak. Its 
affinity for the opioid receptor is only 1/6000 that of morphine. 
Unlike other opioids, it inhibits reuptake of nor- adrenaline and 5-
hydroxytriptamine and thus activates monoaminergic spinal 
inhibiton of pain. Its analgesic action is only partially reversed by 
opioid antagonist naloxone.  
It is a racemic mixture of 2 enantiomers (+) tramadol and (–) 
tramadol and has chemical structure: (IR, 2R)–ve/–2–{(dimethyl 
amino) methyl]-1-(3-methoxyphenyl) cyclohexaonl hydrochloride.  
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Chemical structure 
Molecular formula : C 16 H 25 NO 2 HCl  
  
Characteristics:  
• White to off white crystalline 
• odourless 
• Soluble in water and ethanol                                  
• Characteristic unpleasant taste which is mildly bitter 
• Molecular weight-299.84 
• pH 6-6.8  
• pKa value is 9.3 at 293 K  
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Available as capsules, drops, suppositories and injections. Solution for 
injection contains 50 mg/ml of tramadol hydrochloride in an 
adequatesodium acetate buffered solution without preservative.  
 
 
 
 
 
 
 
Mechanism of Analgesia: 
The antinociceptive action of tramadol hydrochloride is mediated 
by two components:  
1. Opioid pathway: Tramadol interacts with µ, κ and δ receptors 
where it exhibits purely agonist effects. It has moderate affinity 
for µ receptors and weak affinity for δ and κ receptors. The 
duration of antinociceptive is relatively long being comparable 
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to morphine and longer than that of codeine and 
dextropropoxyphene. The opioid component of analgesia is 
reversed by naloxone. 
2. Non-opioid pathway: Tramadol hydrochloride inhibits the 
reuptake of nor-adrenaline and 5-hydroxy tryptamine 
(serotonin) and activates monoaminergic spinal inhibition of 
pain by elevating the pain threshold. 
It is also 5 HT2C receptor antagonist and Nicotinic ,M1 and M3 
Muscarinic receptor antagonist,NMDA antagonist and GABA-
A receptor inhibitor. 
Pharmacokinetic properties 
Absorption :  
The bioavailablity following oral administration of the drug is 
68 to 100%.It is 100% available when administered 
intramuscularly22 
Distribution: 
The drug is 20 % protein bound in the plasma. 80% of the 
administered dose crosses the placenta 
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Metabolism: 
85% of the administered dose is metabolized by demethylation 
in liver via cytochrome P450 iso zyme. The metabolite           
O- desmethyl tramadol is active and has 200 times µ affinity of 
that of tramadol. It binds to µ opioid receptor and exerts its 
effects on GABAnergic transmission. 
Excretion: 
Excretion is 90% through the kidneys. Remaining is excreted in 
the faeces.The T1/2 is 5 hours. The elimination half-life is 5-6 
hours. The elimination half life is doubled in patients with 
hepatic or renal impairment. So it is not recommended in 
patients with end stage renal failure. 
Therapeutic Efficiency:  
Intramuscular tramadol 50-150 mg is found to be equal to 50-
100mg IM pethidine and 100 mg Tramadol equal to 10 mg 
morphine.     
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Dose: 
50 -150mg  or 1-2 mg/kg 4-6 hourly. 
A daily dose of 400 mg is sufficient. 
Administration: 
Oral ,intramuscular, intravenous ,per rectal or as a part  of  patient 
controlled  analgesia. 
Actions:  
Respiratory System: Therapeutic doses of tramadol has no significant 
effect on respiratory rate, tidal volume, arterial carbon dioxide tension, 
ventilatory carbon dioxide response. A decrease in respiratory rate is due 
to effective analgesia rather than respiratory depression. Over dosage 
may cause respiratory depression.  
Cardiovascular System: In therapeutic doses tramadol has no 
significant effect on the cardiovascular system except for transient 
reduction in pulmonary artery pressure. Hence, it is suitable for pain 
relief in cardiac patients e.g., acute myocardial infarction and in 
diagnostic cardiac catherizations. 
Central nervous system: It has an analgesic potency equivalent to 
pethidine.  
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Other Effects: Tramadol has minor direct action on smooth muscle, 
hence it is likely to cause cholestasis, urinary retention and constipation. 
It produces dose dependent mydriasis and antitussive effect. In contrast 
to morphine, it does not produce dependence, tolerance and addiction 
even after long-term use.   
Indication: Tramadol can be used for treating moderate to severe acute 
pain and chronic pain resulting from cancer, surgical procedure, trauma, 
myocardial infarction, obstetric pain, painful diagnostic procedures. 
Interaction with other Drugs: Tramadol should not be combined with 
MAO inhibitors (e.g., anti-depressants).  
Contraindications: Contraindicated in cases of acute intoxication with 
alcohol, hypnotics, analgesics or CNS acting drugs.Seizures are 
particularly likely during tramadol  intravenous injection in patients with 
epilepsy.  
Side effects: Dry mouth, nausea, vomiting,fatigue, hot flushes, transient 
tachycardia, sweating, dizziness.  
Overdose and Intoxication: Symptoms are restlessness, salivation, 
ataxia, cyanosis, prostration, mydriasis, dyspnoea, cramps, tremor, 
vomiting.  
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Opioid Antagonists: Naloxone (Nurcan) is the opioid antagonist of 
choice for reversing neonatal asphyxia due to opioid use during labour. 
Giving naloxone to the mother before delivery has not showed any 
benefit. This antagonizes maternal analgesia during labour or at delivery 
without causing a decrease in opioid related maternal side effects. When 
maternal administration of opioids is anticipated to result in neonatal 
respiratory depression, about 10µg/kg of naloxone is given in the cord. 
Other routes are subcutaneous, intramuscular and intravenous. Naloxone 
reverses opioid depression of newborn minute ventilation and increases 
the slope of carbon dioxide response curve in infants affected by 
maternal administration of an opioid. The recommended dose is 0.1 
mg/Kg of a 1 mg/ml or 0.4 mg/ml solution.  
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REVIEW OF CLINICAL TRIALS WITH TRAMADOL AS 
LABOUR ANALGESIC 
Maryam khooshideh and Ali shahriari in 2009, studied in hundred 
and sixty full-term parturients, the effect of  Intramuscular  tramadol 
100mg versus 50 mg of intramuscular pethidine.Lower incidence of 
maternal side-effects and shorter  duration of labour  was  seen in the 
tramadol group . Both the drugs  provide moderate analgesia in first stage 
of labour but pethidine is more effective in the second stage.4 
Rao ZA et al, in 2010 conducted a non randomized controlled trial to 
compare the  duration of labour and mode of delivery between routine 
labour practice and walking epidural analgesia with 0.5%  tramadol  with 
0.1% Bupivacaine .They showed that it markedly reduces the duration of 
labour.  
Fieni S, Angeri F et al (2000) studied the efficacy and tolerability of 
parenteral tramadol and meperidine as labour analgesics and concluded 
that tramadol gives an analogous analgesic effect with better tolerability 
without maternal and neonatal complications.23 
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Bitsch M et al (1980) compared parenteral tramadol used in 23 
normal deliveries and pethidine. Both demonstrated identical analgesic 
effects. The tramadol group did not have any labour or neonatal 
complications. Thus, he recommended tramadol for obstetrical analgesia 
since it does not exert inhibitory effects on the respiration centre.24 
Hussein P et al, in 1987 compared tramadol 100 mg with pethidine 
100 mg on 40 women asking for pain relief during labour. The pethidine 
group showed a slightly but not significantly shorter duration of labour. 
Tramadol had a similar analgesic effect but less side effects.25 
Lehman KA (1994) studied the use of tramadol in the management of 
labour pains, MI, trauma associated pain and found that it has good 
results for control of pain associated with labour 26 . 
In 1996, Radbrach L et al studied on management of pain with tramadol 
and found that it has good labour analgesic property but no neonatal 
respiratory depression .27 
In 1997 Sarkar B, Mukhopadhyay AK compared the effect of IM 
tramadol hydrochloride and pethidine in patients with dysfunctional 
labour and normal labour. The analgesic effect was comparable in both 
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groups. But the incidence of FD, CS, duration of  labour was 
significantly less in the tramadol group .28 
Claahsen-Vander Grinten HL et al (2005) investigated the 
pharmacokinetic profile of neonates whose mothers were given tramadol 
hydrochloride.22 mothers who requested for pain relief in labour were 
given IM tramadol hydrochloride (100-250 mg) At the time of birth, 
maternal venous and cord blood samples were drawn. Post partum 
samples at 1, 2, 3, 6 and 12 hours were taken from both  the mother and 
baby. They concluded that IM tramadol given to mothers during labour 
almost freely reaches the neonates. The neonate has a reduced renal 
elimination of its active metabolite. Inspite of this, tramadol is an 
effective labour analgesic.They observed that with tramadol, pain relief 
was 38.92% with minimal changes in cardiorespiratory parameters, 
22.22% had nausea, 11.11% had drowsiness. They found no effect of 
tramadol on the Apgar score. They concluded that tramadol 1 mg/ Kg 
caused mild to moderate relief of labour pain .30 
Usha Rani Sharma, Verma RS (1997), compared tramadol to a no 
drug group. They concluded that tramadol was an effective analgesic 
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without any significant maternal or  neonatal complications and that it 
can be safely administered during labour.29   
Parasertsawat et al in 1986,studied 135 parturients and  compared the 
analgesic effects of tramadol, morphine and pethidine. They observed 
that analgesic effect  in tramadol group was good in  24.5%, satisfactory 
in  53.3% and no response in 22.2%. They found the differences in 
response in all three groups were statistically insignificant. The side 
effects in all the three groups were minimal consisting of drowsiness, 
nausea, vomiting, palpitation. There was no respiratory depression in the 
neonates.31 
In 2001 Singh S studied 60 women and compared 100 mg tramadol 
with 30 mg Pentazocine used as labour analgesics. They observed that 
pain relief with tramadol was 80% and pentazocine was 60%. The 
maternal and fetal complications were slightly more in the pentazocine 
group. 32 
In 2004, Nagesh Kumar conducted a randomized, prospective study 
on 100 women in labour. 50 women received  tramadol, 50 women were 
given  distilled water. He concluded that IM tramadol can be used as safe 
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labour analgesic in any health centre even with least monitoring facilities 
unlike other opioids because of negligible side effects at therapeutic dose 
either on mother or fetus. There was also significant shortening of 
duration of labour in the  tramadol group .33 
Elbourne D, Wiseman RA (2000) studied sixteen trials to assess the 
effect of intramuscular opiods as labouranalgesic. Interval to delivery, 
pain relief or instrumental or operative delivery  did not differ between 
tramadol and pethidine.34 
  Meena Jyothi, Singhal Prabha, Choudary Devika (2006) evaluated 
the various effects of programmed labour protocol in primi parae. They 
concluded that programmed labour  provides effective labour analgesia, 
augments the process of labour and reduces third stage blood loss. It has 
no adverse effects on the foetus.35 
Nagaria tripti, Acharya Jyotsna in 2006 compared intramuscular 
tramadol hydrochloride and pentazocine as an analgesic during labour in 
200 term parturients. They found that pain relief was satisfactory in 37% 
and moderate in 38% and mild in 16% in tramadol group, and 
satisfactory in 14%, moderate in34% and mild in 42% of penatzocine 
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group. The total duration of labour and interval between injection and 
delivery, side effects were less in tramadol group.36 
Sudha patil et al (2012) studied the efficacy and safety of intramuscular 
tramadol hydrochloride 100mg as analgesia for labour in 100 
primigravida. Good pain relief was noted in 58% of parturients, moderate 
pain relief in 30% and mild pain relief in 12%.37 
Viegus OA et al in 1993 compared in 90 labouring primiparae the 
analgesic efficacy and safety of intramuscular pethidine 75mg, tramadol 
50mg, tramadol 100mg. Pain relief is similar with both 100mg tramadol 
and pethidine 75mg. Adverse effects and respiratory depression are 
common in the pethidine group. Thus tramadol has a superior safety 
profile than pethidine.38 
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MATERIALS AND METHODS 
Type of study: This is a prospective comparative interventional 
study.  
Population under study: Primigravida with full term singleton 
pregnancy admitted in labour at Institute of Obstetrics & Gynaecology, 
Egmore from August 2011 to August 2012.  
Methodology: 
 400 primigravid women with singleton term gestation admitted in labour 
were selected according to inclusion and exclusion criteria.  
INCLUSION CRITERIA: 
Primigravid women with 
1. Singleton live foetus with satisfactory admission CTG. 
2. Gestational age between 37 – 42 weeks. 
3. Vertex presentation with no evidence of CPD. 
4. In active phase of labour. 
Criteria for active phase of labour: well effaced cervix, dilatation more 
than 4 cm, good uterine contractions i.e. 3 contractions in 30 minutes 
each  lasting for atleast 35-40 seconds.  
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EXCLUSION CRITERIA: 
1. History of hypersensitivity to the drug. 
2. Women with associated medical conditions like heart disease, 
chronic hypertension, epilepsy, respiratory and renal diseases. 
3. Associated obstetric complications like APH, GDM, hypertension 
in pregnancy, CPD, multiple gestation. 
Informed consent was obtained from the patients and allocated in 2 
groups, Group A and Group B. 
GROUP A: Study group: 200 women in study were given 100mg 
Intramuscular injection Tramadol hydrochloride 
GROUP B: Control group: 200 women in active labour who did not 
receive tramadol. 
Study group A  
In patients with 4 cm cervical dilatation and in established active 
phase of labour, 
• vital signs were recorded  
• pain score noted before drug administration.  
• Severity of labour pains assessed by NPI scale . 
• Intramuscular injection Tramadol 100mg given.  
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• Vital signs and pain score were recorded after drug 
administration. 
• Partogram was maintained and progress of labour assessed. 
• Injection syntocinon for augumentation of labour if contractions 
were inadequate. 
• Another 100mg tramadol was given after 4 hours if the patient 
complained of increasing pain except in patients who had 
already reached the second stage. 
• Routine neonatal care given. 
Study group B 
In patients in active phase of labour,  
• Vital signs were recorded  
• Pain score recorded.  
• Partogram to assess the progress of labour. 
• Labour augmented with syntocinon if required. 
The pain score of the patients, onset of drug action, progress of 
labour, duration of labour, mode of delivery, APGAR scores of the new 
born, complications during the course of labour, associated side effects, 
change in vital parameters, fetal heart rate were noted in both the groups.
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 PAIN ASSESSMENT   
The pain score was measured by numeric pain intensity scale. 
  
 
        0-1: NO PAIN 
2-4:MILD PAIN  
5-7:MODERATE PAIN  
8-10:SEVERE PAIN  
During labour, after administration of drug, if patients had pain 
score of 0-1(no pain), they  were considered to have good pain relief. 
When patients had pain score between 2 and 4 (mild pain) they 
considered to have moderate pain relief. When pain score was from 5-7 
and 8-10, patients were considered to have mild pain relief and no pain 
relief respectively. 
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RESULTS AND ANALYSIS 
Continuous variables are presented as mean with standard deviation. 
Comparisons between groups and within groups were made using 
Pearson Chi Square Test or t-test as appropriate. Differences in the 
compared groups were considered as statistically significant if, P value is 
<0.05.  
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 (Table-1) 
 STUDY CONTROL
25 (12.5%) 20 (10%)
127 (63.5%) 136 (68.0%)
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7 (3.5%) 5 (2.5%) 
2 (1%) 0 (0%) 
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The Mean gestational age in the study group is 38weeks
The Mean gestational age in the control group is 38weeks 5days
The gestational age in both groups is comparable
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STUDY CONTROL 
22(11%) 27(13.5%) 
46(23%) 69(34.5%) 
113(56.5%) 88(44%) 
18(9.5%) 16(8%) 
 4 days
. 
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No Effect
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Mean duration of onset of drug action is 
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(Table -3) 
 IN 
NUMBER OF 
PATIENTS 
PERCENTAGE
14 7.0% 
17 8.5% 
52 26.0% 
78 39.0% 
33 16.5% 
6 3.0% 
18.31± 6.5 minutes
30
 
 
 
 
 
 
. 
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PAIN IN STAGE I (Table – 4) 
DEGREES OF PAIN STUDY CONTROL 
NO PAIN (0-1) 0 0 
MILD(2-4) 0 0 
MODERATE(5-7) 25(12.5%) 15(17.5%) 
SEVERE(8-10) 175(87.5%) 185(92.5%) 
 
In stage I,87.5% of the patients in the study group and 92.5% of  the 
control group had severe pain and 12.5% of patients in study group and 
17.5% of the control group had moderate pain. 
The pain score before drug administration is comparable in both groups 
 (p value-0.368). 
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PAIN IN STAGE I BEFORE AND AFTER DRUG 
ADMINISTRATION (Table – 5) 
DEGREES OF PAIN 
STAGE I 
BEFORE DRUG 
STAGE I AFTER 
DRUG 
NO PAIN  0 0 
MILD PAIN(0-1) 0 136(68%) 
MODERATE(2-4) 25(12.5%) 27(13.5%) 
SEVERE(8-10) 175(87.5%) 11(5.5%) 
 
There is a significant decrease in the pain score after drug administration 
in stage I (p value < 0.0001). 
There was moderate pain relief in 68% of patients and mild pain relief in 
13.5% of patients and no pain relief in 5.5% of patients. 
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PAIN IN STAGE II  IN STUDY AND CONTROL GROUP      
(Table – 6) 
DEGREES OF 
PAIN 
STUDY CONTROL 
MILD(2-4) 28(16.1%) 0 
MODERATE(5-7) 77(44.25%) 0 
SEVERE(8-10) 69(39.7%) 172(100%) 
TOTAL 174 172 
 
(26 Cases In Study Group and 28 Cases in Control Group  had LSCS) 
In the study group 39.7% patients had severe pain,44.25% had moderate 
pain and 16.1% had mild pain. 
In the control group all patients had severe pain. 
The pain in stage II in study group was less than control group which is 
statistically significant.(p value < 0.001). 
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This shows the distribution of pain scores before administration of the 
drug in stage 1 and after drug in stage 1 and stage 2. 
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MEAN PAIN SCORE IN LABOUR (Table – 6) 
PAIN GROUP MEAN 
STANDARD 
DEVIATION 
STAGE 1 
BEFORE 
DRUG 
STUDY 9.13 1.11 
CONTROL 9.16 0.97 
STAGE 1 
AFTER DRUG 
STUDY 4.05 1.77 
CONTROL - - 
STAGE 2 
STUDY 6.65 1.81 
CONTROL 9.61 0.59 
The mean pain score before drug administration in stage I was 9.13 ±1.11 
in study group and 9.16±0.97 in the control group which is comparable. 
(p value 0.37) 
The mean pain in stage I in study group decreased to 4.05±1.77 which is 
statistically significant. The mean score in stage II in study group is 6.65 
± 1.81and in control group it is 9.61±0.59. 
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DURATION OF LABOUR (Table – 7) 
DURATION 
OF LABOUR 
(min)  
GROUP NUMBER MEAN SD P value 
STAGE 1 
STUDY 200 251.05 57.21 
0.0005 
CONTROL 200 272.49 59.44 
STAGE 2  
STUDY 174 27.49 13.16 
0.575 
CONTROL 172 26.72 12.81 
STAGE 3 
STUDY 174 8.66 3.17 
0.11 
CONTROL 172 9.2 3.19 
 
The mean duration of stage I in study group was 251.05± 57.21 minutes. 
In the control group it was 272.49±59.44 minutes. The mean duration of 
stage I is less in the study group compared the control group                   
(p value 0.0005). 
The mean duration of stage II in study group was 27.49±13.16 minutes 
and in control group was 26.72± 12.81 minutes. There is no statistically 
significant difference between the two groups in the mean duration of 
stage II (p value 0.575). The mean duration of stage III in both groups is 
comparable (p value 0.11). 
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TOTAL DURATION OF LABOUR (Table – 8) 
TOTAL DURATION OF 
LABOUR (min) Study Group Control Group 
< 180 2 (1.1%) 2 (1.2%) 
181 – 240 42 (24.0%) 33 (19.1%) 
241 – 300 72 (41.1%) 47 (27.2%) 
301 – 360 33 (18.9%) 57 (32.9%) 
> 360 26 (14.9%) 34 (19.7%) 
Total 175 173 
 
The average total duration of labour in the study group is 
287.21±65.43minutes. 
The average total duration of labour in the control group is 
307.55±68.31minutes. 
The total duration of labour is significantly less in patients who were 
given tramadol than in patients in the control group(p value 0.0063). 
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76.5% of the study group and 77.5% of the control group had normal 
vaginal delivery. There was no difference 
terms of the mode of delivery.
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LSCS
FORCEPS
6
26
155
28
12
Study Group
Control Group
 (Table – 9) 
Study Group 
Control 
Group 
153 (76.5%) 155 (77.5%) 
6 (3%) 5 2.5%) 
26 (13%) 28 (14%) 
15 (7.5%) 12(6%) 
between the two groups in 
 
 
 
 
 
 
 CPD
FAILED ACCELERATION
FETAL DISTRESS
Total
INDICATIONS FOR LOWER SEGMENT CAESAREAN 
SECTION (Table 
CAESAREAN 
INDICATIONS
CPD 
FAILED 
ACCELERATION 
FOETAL DISTRESS
Total 
 
Foetal distress is the most common indication for LSCS in both study 
group (53.8%) and control(59.3%) group. There is no statistically 
significant difference
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Study Group Control Group 
6 (23.1%) 7 (25.9%) 
 
6 (23.1%) 5 (18.5%) 
 14 (53.8%) 16 (59.3%) 
26 28 
.  
 
 
 
 
 
 
 PATIENTS REQUIRING OXYTOCIN FOR AUGMENTATION
OF LABOUR (Table 
PATIENTS 
REQUIRING 
OXYTOCIN
Yes 
No 
Total 
 
There is no statistically significant difference between the two groups in 
terms of oxytocin requirement.
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Study Group Control Group
160 (80.0%) 158 (79.0%)
40 (20.0%) 42 (21.0%)
200 200
 
Yes
No
160
40
158
42
Study Group
Control Group
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ADVERSE EVENTS (Table -12) 
ADVERSE EVENTS Study Group Control Group P Value 
NAUSEA 37 (18.5%) 10 (5.0%) <0.0001 
VOMITING 19 (9.5%) 11 (5.5%) 0.075 
DROWSINESS 5 (2.5%) 0 0.024 
PALPITATION 0 0 - 
HYPER SENSITIVITY 0 0 - 
RESPIRATORY 
DISTRESS 
0 0 - 
FETAL 
TACHYCARDIA 
0 0 - 
  
There is statistically significant increase in nausea (P <0.0001) and 
drowsiness (P 0.024) in the study group than in the control group. 
Though incidence of vomiting was higher in the study group, it is not 
statistically significant. 
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NEONATAL OUTCOME BASED ON APGAR SCORE (Table – 13) 
APGAR 
SCORE1 
MIN 
STUDY CONTROL P VALUE 
3-5 0 1(0.5%) 0.317 
6-7 25(12.5%) 23(11.5%) 0.758 
8-10 175(87.5%) 176(88%) 0.879 
 
APGAR 
SCORE 5 
MIN 
STUDY CONTROL P VALUE 
3-5 0 0 - 
6-7 2(1%) 2(1%) 1 
8-10 198(99%) 198(99%) 1 
FOETAL HEART RATE (Table – 14) 
 
FHR 
 
MEAN SD 
ONSET OF LABOUR 139.23 5.98 
AT TIME OF INJ 138.92 4.95 
30 MIN AFTER 139.4 8.68 
 
There is no significant change in the mean fetal heart rate before and after 
administration of drug. 
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CARDIORESPIRATORY PARAMETERS AT THE  ONSET OF 
LABOUR  IN STUDY AND CONTROL GROUP (Table – 15) 
 
STUDY GROUP CONTROL GROUP P 
VALUE MEAN SD MEAN SD 
PULSE RATE 79.34 4.18 79.75 3.59 0.254 
RESPIRATORY 
RATE  
16.01 1.42 17.45 1.96 0.37 
SYSTOLIC BP 111.41 5.96 112.69 5.42 0.25 
DIASTOLIC BP 72.18 5.23 71.78 4.64 0.419 
 
The cardiorespiratory  parameters are similar in both groups at the onset 
of labour. 
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MATERNAL CARDIORESPIRATORY PARAMETERS IN THE 
STUDY GROUP (Table – 16) 
MATERNAL 
PARAMETERS  TIME MEAN SD 
PULSE RATE 
Onset of labour   79.34 4.18 
Time of injection  79.67 3.97 
30 min after inj  79.41 3.99 
After delivery 79.37 4.18 
RESPIRATORY 
RATE  
Onset of labour  16.015 1.423 
Time of injection  16.015 1.633 
30 min after inj  16.24 3.16 
After delivery 16.355 1.698 
SYSTOLIC 
BLOOD 
PRESSURE 
Onset of labour  111.41 5.96 
Time of injection  111.79 4.21 
30 min after inj  111.685 4.38 
After  delivery 110.735 4.79 
DIASTOLIC 
BLOOD 
PRESSURE 
Onset of labour  72.18 5.23 
Time of injection  72.13 3.97 
30 min after inj  72.53 3.82 
After delivery 72.89 3.6 
 
There was no significant change in the vital parameters after drug 
administration in the study group. 
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DISCUSSION 
The American Academy of Paediatrics and American college of 
Obstetricians and Gynaecology (2007) have specified that it is the 
responsibility of the obstetrician or certified midwife in consultation with 
an anaesthesiologist   to formulate pain relief . In the present study, 400 
patients were studied. Study group: 200 patients in active labour who 
received 100mg  tramadol hydrochloride Control  group:200 patients in 
active labour who did not receive the drug. 
AGE  
The mean gestational age in the study group was 
22.81+_3.27 years and 22.54+_2.81 years in the control 
group.76% of the study group and 78% of the control group were 
less than 25 years. This is comparable to the study by Thakur ratna 
et al 48 the mean age was 22 years. 
GESTATIONAL AGE  
Primiparous patients between 37 to 42 weeks were included 
in the study. The mean gestational age in study group was 38 
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weeks 4days and 38weeks 5days in the control group. In the study 
by Nagaria tripti et al 36and sudha patil et al 37 the mean gestational 
age was 39 weeks.  
In this study all patients were primigravidae. Similarly in a 
study by Jain et al, Viegas O A et al 38 ,Lie et al 49 all women were 
primigravida.  
ONSET OF ANALGESIA  
In the present study, time required for onset of analgesia was 
18.31± 6.5 minutes.  
It was 15.89± 6.61 minutes in a study by Nagaria tripti  et al 36. In 
a study by Sudha Patil 37the time for onset of analgesia was 
15.35±2.65 minutes. 
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DEGREE OF ANALGESIA ACHIEVED   
Degree of 
pain relief 
Nagaria 
Tripti 
Thakur 
rathna 
Meena 
Jyothi 
Sudha 
Patil 
Sarkar  B, 
Mukhopadhyay 
Present 
study 
Complete 
pain relief 
37% 15% 54% 58%     13% 0 
Moderate 
pain relief 
38% 55% 32% 30% 38% 68% 
Mild pain 
relief 
16% 16% 14% 12% 45% 13.5% 
No pain 
relief 
9% 14% 0% 12% 47% 5.5% 
 
In the present study, 68% had moderate pain relief, 13.5% had mild pain 
relief and 5.5% had no pain relief at all after administration of tramadol. 
The mean pain score before the drug was 9.13±1.11. It was reduced after 
drug administration and was 4.05±1.77. 
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This is comparable to studies conducted by Nagaria Tripti et al 36 where 
75% of patients had moderate to good pain relief and Thakur ratna et al 48 
where 70% patients had good pain relief.  
In a prospective blind randomized study Bajaj et al 50 noted that 
mean pain relief was 38.92% with tramadol .In a randomized control trial 
conducted by Jain et al compared the analgesic efficacy  of intramuscular 
opioids,meperidine and tramadol with epidural analgesia, 65% patients 
rated analgesia as good in the tramadol group.  
Li E and Weng et al 49 observed that effective pain relief was seen 
in 67% patients given 100mg tramadol hydrochloride in active labour.  
O Kuti et al 40 in a study comparing tramadol hydrochloride and 
pentazocine in labour found that 30.9% patients had moderate pain relief 
and 66% patients had mild relief with tramadol.  
Singh S et al 32 in a study comparing 100 mg IM tramadol and 
pentazocine as labour analgesics observed that moderate pain relief with 
tramadol was 80%.  
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As shown in table, in stage II there is an increase in pain score, 
with 39.7% of patients experiencing severe pain and 44.25% 
experiencing moderate pain and 16.1% experiencing mild pain.  
There is a significant increase in pain from stage 1 to stage 2 in the 
study group. Howover compared to the control group, where 100% 
experienced severe pain in stage II, the pain in stage II in study group is 
significantly reduced.  
DURATION OF LABOUR  
The average duration of labour in the study group was 
287.21±65.43 minutes and 307.55 ± 68.31 minutes in the control group. 
The total duration of labour is significantly less in the study group          
(p value 0.0063)  
Duration 
of 
labour 
Thakur 
Rathna     
et al48  
Nagaria 
Tripti       
et al 36 
Khooshid
eh M, Ali 
Shahriari4 
Sudha 
Patil 37 
Present 
study 
STAGE 
I 4.26±1.62 
hours 
4.28±2.22 
hours 140 min  
4.15 
±1.68 
hours 
251.05±57.
21 min 
STAGE 
II 11.95±5.8
min 
0.30±0.05 
hours 25 min 
0.28               
±0.42 
hours 
27.49±13.1
6 min 
STAGE 
III 5.5±1.5 
min 
0.04±0.01
5 hours  
0.08±0.0
5 hours 
8.66±12.81
min 
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  The average duration of stage 1 in study group was 251.05±57.21 
minutes but in control group it was 272.49±59.44 minutes. The duration 
of first stage is significantly less in the study group compared to the 
control group (p value <0.0005). Though the duration of stage 2 and 
stage 3 were less in study group the difference is not statistically 
significant.  
As shown in the table the duration of  labour is significantly less in 
patients given tramadol in studies conducted by  Nagaria Tripti et al,  Ali 
shahriari and M.Khoosideh, Sudha patil.  
Sarkar B and Mukhopadhyay A K and suvonnakote et al reported 
rapid progression in women receiving tramadol. 
MODE OF DELIVERY 
In the study group 76.5% had normal vaginal delivery, 13% 
underwent LSCS and 7.5% had forceps delivery and 3% had vacuum 
delivery. There was no significant difference in the mode of delivery 
when compared to the control group.  
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Mode of 
delivery 
Thakur 
Ratna   
et al 48 
Nagaria 
Tripti     
et al 36 
O Kuti     
et al 40 
Sudha 
Patil 37 
Present 
study 
NVD 98% 93% 88.1% 90% 76.5% 
LSCS 0 3% 9.5% 4% 13% 
Instrumental 
delivery 
2% 4% 2.4% 6% 10.5% 
 
Side Effects  Thakur 
Ratna 
et al48 
Nagari
a Tripti    
et al36 
O Kuti 
et al40 
Bajaj P     
et al50 
Khooshideh 
et al 4 
Presen
t study 
Nausea 7% 11% - 22.2% 15% 18.5% 
Vomiting 3% 4% 2.4% - - 9.5% 
Drowsiness 2% 1% 14.3% 11.1% 29% 2.5% 
Palpitation 1% - - - - - 
Hyper sensitivity - - - - - - 
Dry mouth 10% - - - - - 
    
In the present study in comparison to the control group there is a 
statistically significant increase in nausea (p value < 0.0001) and 
drowsiness (p value 0.024). Vomiting is also increased in study group 
compared to the controls, but is not statistically significant. 
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FETAL HEART RATE 
  As shown in table, there is no significant change in the mean fetal 
heart rate before drug and 30 minutes after administration of the drug.  
Nagaria Tripti et al did not observe any change in the fetal heart rate after 
administration of tramadol. 
NEONATAL OUTCOME 
ANALYSIS OF THE APGAR SCORES 
In the present study, there is no difference in the APGAR scores of 
the newborn between the study and control group. This shows that there 
is no effect of the drug on the neonatal outcome. 
In the present study, 87.5% neonates had APGAR scores ≥8 at 1 
minute and 99% neonates had APGAR score ≥8 
Bajaj P et al reported 1 minute APGAR score >8 in all neonates in 
the tramadol group. 
MATERNAL CARDIO RESPIRATORY PARAMETERS  
In this study there is no significant change in the maternal cardio 
respiratory parameters after drug administration. 
84 
 
SUMMARY 
This study is a prospective comparative interventional study.  
200 patients were allocated to the study group and another 200 to 
the control group.  
The study group received 100 mg of injection tramadol 
hydrochloride intramuscularly when they reached active labour.  
Degree of pain relief was assessed using numeric pain relief score. 
Duration of all three stages were calculated in both the groups.  
Other parameters like onset of drug action, mode of delivery, 
maternal cardio respiratory parameters, fetal heart rate and neonatal 
APGAR score were assessed.  
There was a significant decrease in the pain score after drug 
administration in stage 1 (p value < 0.0001).  
There was moderate pain relief in 68% of patients and mild pain 
relief in 13.5% of  patients and no pain relief  in 5.5% of patients. After 
drug administration in the study group 39.7% patients had severe 
pain,44.25% had moderate pain and 16.1% had mild pain. In the control 
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group all patients had severe pain he pain. The second stage pain  in the 
study group is lesser than in the control group which is statistically 
significant.(p value-<0.001).  
The average duration of labour in the study group was 
287.21±65.43minutes and    307.55±68.31 minutes in the control group. 
The total duration of labour is significantly less in the study group(p 
value 0.0063). 
 The duration of first stage is significantly less in the study group 
compared to the control group (p value <0.0005). Though the duration of 
stage 2 and stage 3 are less in study group the difference is not 
statistically significant. 
 In the present study in comparison to the control group there is a 
statistically significant increase in nausea (p value < 0.0001) and 
drowsiness ( p value 0.024). Vomiting was also increased in study group 
compared to the controls, but is not statistically significant.  
There was no respiratory depression in any of the new borns the 
study group. There was no alteration in the maternal cardio respiratory 
parameters with the drug.  
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CONCLUSION 
Tramadol hydrochloride is a safe and effective drug for pain relief 
in active labour. It also causes a significant reduction in the duration of 
labour. The tolerance is good without any adverse effects on the mother 
and newborn.  
Tramadol can be instituted as a safe and effective drug for pain 
relief in labour.  
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ABBREVIATIONS 
APH               ANTEPARTUM HAEMORRHAGE 
ACOG            AMERICAN COLLEGE OF OBSTETRICS AND                
                        GYNAECOLOGY 
ACTH             ADRENO CORTICO TROPIC HORMONE 
BP                   BLOOD PRESSURE 
CPD                CEPHALO PELVIC DISPROPORTION 
CTG                CARDIOTOCOGRAM 
FD                   FETAL DISTRESS 
IM                   INTRA MUSCULAR 
I V                   INTRA VENOUS 
GDM              GESTATIONAL DIABETES MELLITUS 
LSCS              LOWER SEGMENT CAESAREAN SECTION 
NPI                  NUMERIC PAIN INTENSITY SCALE 
  
NSAIDS          NON STEROIDAL ANTI INFLAMMATORY        
DRUGS 
ODA               ONSET OF DRUG ACTION  
PCA                PATIENT CONTROLLED ANALGESIA 
PIH                 PREGNANCY INDUCED HYPERTENSION 
PR                  PULSE RATE 
RS                  RESPIRATORY RATE 
SD                  STANDARD DEVIATION 
TDD               TOTAL DOSE OF DRUG 
TENS             TRANS CUTANEOUS ELECTRIC NERVE 
STIMULATION 
VAS               VISUAL ANALOGUE SCALE 
VD                 VAGINAL  DELIVERY 
VRS               VERBAL RATING SCALE 
 
 
  
PROFORMA 
S.NO 
NAM E :                                                               IPNO: 
AGE:                                                                     SE STATUS: 
BOOKED/UNBOOKED: 
DATE AND TIME OF DELIVERY: 
CHIEF COMPLAINTS AND HISTORY OF PRESENTING ILLNESS: 
H/O ________ AMENORHOEA 
C/O LABOUR PAINS ________ HOURS 
H/OLEAKING P/V OR BLEEDING P/V_________ HOURS 
MENSTRUAL HISTORY: 
LMP:                               EDD: 
REGULAR /IRREGULAR: 
DAYS OF FLOW:  
DURATION OF CYCLE: 
  
OBETETRIC HISTORY: PRIMI 
I TRIMESTER: 
II TRIMESTER: 
III TRIMESTER: 
PAST HISTORY: HT/DM/TB/BA/HEART DISEASE/DRUG 
HISTORY 
FAMILY HISTORY: HT/DM/TB/BA/TWINS  
PERSONAL HISTORY: 
DIET:         APPETITE:        SLEEP:        BLADDER:         BOWEL: 
GENERAL EXAMINATION  
BUILT:              NOURISHMENT: 
HEIGHT:           WEIGHT: 
PALLOR:          ICTERUS:            PEDAL EDEMA: 
LYMPHADENOPATHY:        THYROID:          BREAST: 
VITALS 
  
PULSE RATE:             BP: 
RR:                               TEMP: 
SYSTEMIC EXAMINATION  
CVS:  
RS: 
CNS: 
 OBSTETRIC EXAMINATION  
P/A:UTERUS_______ WEEKS , ACTING  
LONGITUDINAL LIE/CEPHALIC PRESENTATION  
HEAD: 
FHR:            
SFH:             EFW: 
P/S 
P/V CERVIX      CONSISTENCY 
                            EFFACEMENT 
  
                            DILATATION  
                             MEMBRANES 
LIQUOR 
VERTEX STATION :          POSITION : 
PELVIC ASSESSMENT 
INVESTIGATIONS 
Hb:        TC:        DC:         BLOOD GROUPING:           RBS:     
URINE ROUTINE:             
HIV:            HbsAg: 
  
 
 
 
 
 
 
 
 
  
MONITORING DURING LABOUR AFTER DRUG 
ADMINISTRATION  
Date &time      
Pulse      
BP     
RR     
UT contraction     
FHS     
PV      
Pain score     
Tramadol dose 
and time 
    
 
OBSERVATIONS  
a) Degree of pain before administering the drug 
b) Degree of pain after administering the drug  by NPI scale 
Stage 1:            stage 2 
  
c) Effect on bearing down :satisfactory or not 
d) Onset of drug action : 
e) Duration of drug action : 
f) Total dose of drug: 
DELIVERY DETAILS  
MODE OF DELIVERY: 
VAGINAL: NORMAL/FORCEPS/VACUUM 
LSCS:             INDICATION : 
ANY ADVERSE EFFECTS OF THE DRUG: 
Nausea :      Vomiting:     Respiratory depression:    Drowsiness: 
BABY DETAILS 
Sex:     birth weight:       Time of delivery: 
APGAR:1”       5” 
NICU Admissions: 
 
 
  
PATIENT CONSENT FORM 
STUDY TITLE: A PROSPECTIVE STUDY ON INJECTION TRAMADOL 
HYDROCHLORIDE AS A LABOUR ANALGESIC AND 
ITS EFFECT ON DURATION OF LABOUR 
STUDY CENTRE:   Institute of Obstetrics and Gynaecology, Egmore, Chennai. 
PARTCIPANT NAME:  AGE:   I.D.NO: 
 I confirm that I have understood the purpose of the above study. I have the 
opportunity to ask the question and all my questions and doubts have been answered 
to my complete statisfaction. 
  I understand that my participation in the study is voluntary and that I am free 
to withdraw at any time without giving any reason, without my legal rights being 
affected. 
 I understand that investigator, the institution, regulatory authorities and the 
ethics committee will not need my permission to look at my health records both in 
respect to the current study and further research that may be conducted in relation to 
it, even if I withdraw from the study. I understand that my identity will not be 
revealed in any information released to third parties or published, unless as required 
under the law. I agree not to restrict the use of any data or results that arise from the 
study. 
 I hereby consent to, undergo complete physical examination, and diagnostic 
tests including haematological, and ultrasonogram examinations for me. 
 I hereby consent to participate in this study on “A PROSPECTIVE STUDY 
ON INJECTION TRAMADOL HYDROCHLORIDE AS A LABOUR 
ANALGESIC AND ITS EFFECT ON DURATION OF LABOUR”.  
 
Place:       Signature of the Patient:  
Date:       Address: 
Signature of the witness:    Signature of Investigator: 
  
 
 
MASTER CHART - STUDY GROUP 
S.NO NAME AGE  IP NO 
GEST 
AGE 
DEGREES OF PAIN 
ODA TDD OXYTOCIN 
  
STAGE 
1  
STAGE 
2 
STAGE 
3 
TOTAL DURATION 
OF LABOUR 
MODE OF 
DELIVERY 
LSCS 
INDICATION 
ADVERSE EVENTS 
APGAR 
SCORE 
BEFORE DRUG 
STAGE 1 
AFTER DRUG 
NAUSEA VOMITING DROWSINESS PALPITATION 
HYPER 
SENSITIVITY 
RESPIRATORY 
DISTRESS 
FETAL 
TACHYCARDIA 
STAGE 
1  
STAGE 
2 
1 
MIN 
5 
MIN 
1 LAKSHMI 26 18268 40+4 10 9 10 NIL 1 YES 300 21 7 328 VD   NO NO NO NO NO NO NO 8 9 
2 GOMATHI 20 17935 39+3 10 3 5 20 2 YES 420 23 5 448 VACUUM   YES NO NO NO NO NO NO 7 9 
3 AABITHA 22 17891 40 7 3 3 15 1 YES 360 16 4 380 VD   NO NO NO NO NO NO NO 8 9 
4 KALPANA 24 17945 38+4 10 6 8 15 2 NO 320 20 5 345 VD   NO NO NO NO NO NO NO 8 9 
5 CHITRA 24 18119 39+1 10 4 8 20 1 YES 180 25 5 210 VD   NO NO NO NO NO NO NO 8 9 
6 NANDHINI 19 17979 40+3 7 3 - 10 1 YES           -     -  -   LSCS CPD NO NO NO NO NO NO NO 8 9 
7 
STEFFI 
EVANGELIN 20 18082 38+1 7 3 5 10 1 YES 240 14 6 260 VD   NO NO NO NO NO NO NO 8 9 
8 MENAKA 29 17978 39+2 10 6 8 15 1 YES 300 17 5 322 VACUUM   NO NO NO NO NO NO NO 8 9 
9 MERCY 24 18122 39+5 9 5 8 10 1 YES 240 25 7 272 VD   NO NO NO NO NO NO NO 8 9 
10 MONA DEVI 22 17928 39+6 10 4   - 15 1 YES         -         -          -   LSCS FD NO NO NO NO NO NO NO 8 9 
11 MEENAKSHI 28 18143 40 9 2 8 15 1 YES 220 17 7 244 VD   NO NO NO NO NO NO NO 8 9 
12 AMMU 26 17957 39+6 10 3 8 16 1 YES 260 15 5 280 VD   YES YES NO NO NO NO NO 8 9 
13 USHA PARVEEN 19 18214 39+3 8 3 8 15 1 NO 220 20 5 245 VD   YES NO NO NO NO NO NO 8 9 
14 ARUNA DEVI 23 18223 40+5 7 3 6 25 1 YES 180 10 8 198 VD   NO NO NO NO NO NO NO 8 9 
15 MAYA SUNDARI 20 18235 39 10 4 5 20 1 YES 230 23 10 263 VD   NO NO YES NO NO NO NO 8 9 
16 DEEPA 27 18296 38+6 10 6 7 25 2 YES 340 20 5 365 VD   NO NO NO NO NO NO NO 8 9 
17 GAJA LAKSHMI 24 18315 39+2 9 6 4 15 1 YES 260 12 5 277 VD   NO NO NO NO NO NO NO 8 9 
18 SELVI 25 18309 38+1 10 5 8 15 2 YES 300 55 5 360 OUT-FOR   NO NO NO NO NO NO NO 8 9 
19 KAVITHA 21 18222 40 9 4 6 15 1 YES 265 12 5 282 VD   NO NO NO NO NO NO NO 7 8 
20 ANUSUYA 35 18383 40+1 8 4 7 15 1 NO 160 37 5 202 VD   YES YES NO NO NO NO NO 8 9 
21 RENUKA DEVI 24 18331 39+5 10 2 4 18 1 YES 220 45 8 273 VD   NO NO NO NO NO NO NO 8 9 
22 RADHIKA 22 18285 38+3 10 2 7 15 1 NO 240 23 10 273 VD   NO NO NO NO NO NO NO 8 9 
23 NITHYA 29 17869 39+1 10 6 9 20 1 YES 260 48 10 318 VD   NO NO NO NO NO NO NO 8 9 
24 VIJAYA LAKSHMI 26 18377 39 10 3 7 20 1 YES 220 38 15 273 VD   YES NO NO NO NO NO NO 6 8 
25 PARAMESHWARI 20 18414 40 8 3 6 25 1 YES 240 30 5 275 VD   NO NO NO NO NO NO NO 8 9 
26 GOMATHI 29 18061 39+5 10 10 10 NIL 1 NO 330 23 7 360 VD   NO NO NO NO NO NO NO 8 9 
27 DURGA DEVI 21 17897 37+2 10 4 8 20 1 YES 230 25 5 260 VD   NO NO NO NO NO NO NO 8 9 
 
 
 
 
  
 
 
PULSE RATE RESPIRATORY RATE SYSTOLIC BLOOD PRESSURE DIASTOLIC BLOOD PRESSURE FETAL HEART RATE 
AT ONSET 
OF 
LABOUR 
AT TIME OF 
INJECTION 
30 MIN 
LATER 
AFTER 
DELIVERY 
AT ONSET 
OF 
LABOUR 
AT TIME OF 
INJECTION 
30 MIN 
LATER 
AFTER 
DELIVERY 
AT 
ONSET 
OF 
LABOUR 
AT TIME OF 
INJECTION 
30 MIN 
LATER 
AFTER 
DELIVERY 
AT ONSET 
OF LABOUR 
AT TIME OF 
INJECTION 
30 MIN 
LATER 
AFTER 
DELIVERY 
AT ONSET 
OF 
LABOUR 
AT TIME OF 
INJECTION 
30 MIN 
LATER 
76 78 80 78 16 17 17 16 112 118 116 112 68 72 74 74 138 134 140 
80 82 82 82 17 15 15 15 110 116 112 112 70 74 78 74 140 138 142 
72 80 76 76 15 14 16 14 120 118 118 112 60 68 66 72 144 140 138 
74 86 80 80 18 18 15 16 108 110 112 114 72 74 68 70 128 132 132 
82 88 82 82 14 16 17 15 106 102 108 114 80 78 74 76 142 140 148 
76 78 76 76 15 14 15 16 110 108 110 112 80 78 76 74 146 144 144 
80 80 74 74 18 18 17 14 114 106 108 108 66 70 72 72 136 138 138 
82 78 80 80 17 14 16 16 116 110 114 112 68 72 72 74 142 138 136 
76 74 82 82 15 16 15 14 110 116 114 114 80 74 76 80 132 138 138 
74 70 76 76 16 15 18 15 104 110 110 114 76 72 70 72 148 144 144 
80 78 78 78 17 14 14 17 100 108 106 114 80 80 74 72 142 138 140 
82 84 80 80 14 17 17 15 118 110 114 112 78 80 76 80 146 142 138 
76 72 82 82 17 15 15 16 110 110 112 112 68 66 70 72 144 144 142 
78 74 76 76 14 14 18 18 114 116 112 110 74 68 72 74 140 142 146 
80 78 78 78 17 18 16 17 120 112 118 104 68 72 74 74 140 138 136 
82 80 80 80 18 16 17 16 112 112 118 104 72 66 70 68 142 136 142 
76 74 82 82 16 17 15 15 118 112 114 116 72 68 70 72 138 140 136 
78 76 88 88 17 15 14 18 106 114 110 110 74 76 80 76 136 144 138 
80 78 78 78 18 14 17 15 110 112 108 110 80 76 80 78 130 132 136 
82 76 80 80 16 17 14 16 108 114 112 106 68 70 66 68 144 140 138 
88 82 82 82 18 16 17 17 112 116 114 120 64 72 68 70 148 142 140 
78 80 80 84 14 17 18 18 108 114 110 120 66 74 76 68 145 144 143 
80 82 82 78 17 15 16 14 110 110 112 104 76 78 74 72 136 138 140 
82 80 82 80 15 14 17 16 110 108 114 106 78 80 76 78 133 132 138 
84 78 80 86 17 18 18 15 104 106 108 108 76 80 78 76 138 140 136 
78 78 86 74 15 16 16 14 106 110 108 110 64 64 68 70 134 142 138 
80 76 80 76 18 14 18 15 110 116 112 112 68 72 74 76 148 146 140 
 
 
 
 
 
  
 
 
 
28 KASTHURI 20 18501 39+1 10 3 8 25 1 NO 240 34 10 284 VD   NO NO NO NO NO NO NO 8 9 
29 SHANTHI 24 18510 39+2 8 3 7 20 1 YES 250 35 5 290 VD   NO NO NO NO NO NO NO 8 9 
30 MUTHU LAKSHMI 22 18521 38+3 9 4 8 15 1 YES 300 20 10 330 VD   NO NO NO NO NO NO NO 8 9 
31 MANJULA 23 18365 39+4 10 7 - 20 2 YES - - -   LSCS FA NO NO NO NO NO NO NO 8 9 
32 JAYANTHI 20 18532 38+5 9 3 9 20 1 YES 360 45 7 412 VACUUM   NO NO NO NO NO NO NO 7 9 
33 SASIKALA 20 18460 39+6 9 3 
               
- 10 1 YES - - -   LSCS FD NO NO NO NO NO NO NO 7 8 
34 PRIYA 19 18534 39+3 10 4 7 25 1 NO 360 25 10 395 VD   NO NO NO NO NO NO NO 8 9 
35 JAYANTHI 23 18234 39+4 10 4 _ 23 1 NO - - -   LSCS FD NO NO NO NO NO NO NO 8 9 
36 UMA MAHESHWARI 24 18376 38+4 10 4 4 25 2 YES 230 35 10 275 VD   NO NO NO NO NO NO NO 8 9 
37 DURGA  18 18664 38+2 10 4 9 20 1 YES 220 20 5 245 VD   NO NO NO NO NO NO NO 8 9 
38 SANGEETHA 21 18467 39+3 7 3 5 15 1 YES 210 17 5 232 VD   NO NO NO NO NO NO NO 8 9 
39 AADHI LAKSHMI 22 18468 40+3 8 3 7 15 1 NO 180 23 10 213 VD   NO NO NO NO NO NO NO 8 9 
40 SANDHYA 24 18583 38+3 10 4 9 25 1 NO 250 50 20 320 VD   NO NO NO NO NO NO NO 8 9 
41 GEETHA 20 18730 39+6 9 4 7 30 1 NO 230 50 10 290 VD   YES YES NO NO NO NO NO 8 9 
42 MEGALA 20 18471 39+4 10 3 6 20 1 YES 145 13 5 163 VD   NO NO NO NO NO NO NO 8 9 
43 TAMILARASI 24 18701 39+5 10 3 4 20 1 YES 190 15 5 210 VD   NO NO NO NO NO NO NO 6 8 
44 DEIVANAI 29 18820 39+6 10 4 3 30 2 YES 320 60 10 390 OUT-FOR   NO NO NO NO NO NO NO 7 8 
45 PALLAVI 20 18363 39+2 10 3 4 25 1 YES 220 20 10 250 VD   NO NO NO NO NO NO NO 8 9 
46 NANDHINI 21 18656 39+1 9 4 - 20 1 YES - - -   LSCS FA NO NO NO NO NO NO NO 8 9 
47 DEEPIKA 20 18810 38+4 9 3 6 20 1 YES 240 20 10 270 VD   YES NO NO NO NO NO NO 8 9 
48 JEEVA 25 18801 39+2 10 4 8 20 1 YES 180 20 10 210 VD   NO NO NO NO NO NO NO 8 9 
49 GAYATHIRI 26 18535 39+4 10 10 10 NIL 1 YES 310 65 10 385 LMC-FOR   NO NO NO NO NO NO NO 8 9 
50 LAKSHMI 19 18728 39+3 10 4 8 25 1 YES 220 30 5 255 VD   NO NO NO NO NO NO NO 7 9 
51 BHAVANI 30 18861 39+3 8 3 6 15 1 NO 200 10 5 215 VD   NO NO NO NO NO NO NO 8 9 
52 DEVI 23 18718 39+2 10 3 8 18 1 YES 180 17 5 202 VD   YES NO NO NO NO NO NO 8 9 
53 BHARATHI 20 18755 40+1 9 3 7 18 1 YES 230 15 5 250 VD   NO NO YES NO NO NO NO 8 9 
54 VASANTHI 31 18801 38+2 10 3 - 20 2 YES - - -   LSCS FD NO NO NO NO NO NO NO 8 9 
55 MEERA 25 18864 38+4 10 4 7 20 1 YES 200 17 10 227 VD   NO NO NO NO NO NO NO 8 9 
56 EPSIBA 20 18948 39+5 9 3 8 25 1 YES 230 42 10 282 VD   NO NO NO NO NO NO NO 8 9 
57 CHAMUNDEESHWARI 25 18955 38+3 10 5 8 25 1 YES 230 25 10 265 VD   NO NO NO NO NO NO NO 7 8 
58 SOWMYA 20 19026 39+2 10 4 8 17 1 YES 270 20 10 300 VD   YES YES NO NO NO NO NO 8 9 
59 KAVITHA 23 19262 38+6 10 9 10 NIL 1 YES 320 25 10 355 VD   NO NO NO NO NO NO NO 8 9 
60 DEEPA 20 19459 40 6 3 3 20 1 NO 240 25 15 280 VD   NO NO NO NO NO NO NO 6 7 
61 KOKILA 21 19517 40+2 9 3 7 15 1 YES 240 30 10 280 VD   YES YES NO NO NO NO NO 8 9 
62 SHAKIRA 21 19636 37+2 10 3 6 15 2 NO 320 50 10 380 VD   NO NO NO NO NO NO NO 8 9 
63 RAJESHWARI 26 19734 37+4 9 4 8 19 1 YES 280 25 10 315 VD   NO NO NO NO NO NO NO 8 9 
64 ANITHA 23 19855 39+2 10 4 6 20 1 YES 240 25 10 275 VD   NO NO NO NO NO NO NO 8 9 
65 AMUDHA 28 19793 39+6 10 5 8 30 1 YES 260 20 8 288 VD   NO NO NO NO NO NO NO 8 9 
66 SHARMILA 19 19877 38+5 10 6 9 20 1 YES 220 25 10 255 VD   NO NO NO NO NO NO NO 8 9 
67 DHANA LAKSHMI 26 19892 37 10 9 9 NIL 1 YES 230 57 10 297 OUT-FOR   YES NO NO NO NO NO NO 7 8 
68 SUDHA 25 19956 39+1 10 9 9 NIL 1 YES 240 35 10 285 VD   NO NO NO NO NO NO NO 8 9 
69 REKHA 22 19935 39+4 10 4 6 25 1 YES 300 40 10 350 VD   NO NO NO NO NO NO NO 8 9 
70 AMMU 20 20110 39+2 9 3 4 20 1 YES 270 20 10 300 VD   NO NO NO NO NO NO NO 8 9 
 
  
 
 
86 84 78 80 16 18 14 16 120 118 118 120 66 74 70 68 144 142 142 
80 84 76 82 16 14 17 15 116 114 112 114 78 74 72 68 138 140 140 
82 86 80 84 17 16 15 18 106 110 112 115 70 70 72 76 140 144 142 
78 78 80 86 16 15 17 16 110 114 112 114 72 68 76 74 142 142 140 
88 84 84 78 17 14 15 15 100 108 110 108 74 74 80 78 144 148 144 
78 80 80 88 16 17 18 18 112 110 110 114 72 76 70 74 138 142 142 
80 82 82 76 17 15 16 16 118 110 110 116 74 68 68 70 136 138 142 
80 78 78 72 15 14 16 15 116 114 112 108 78 72 74 74 136 132 138 
82 80 80 74 17 18 17 17 108 110 112 108 80 76 78 80 142 140 138 
84 82 80 72 16 16 16 18 106 110 112 110 80 78 80 76 140 142 142 
88 80 84 70 15 17 17 14 116 112 114 112 76 72 74 74 140 138 146 
78 74 78 82 18 15 16 17 112 108 114 112 74 74 76 74 140 138 136 
76 72 76 78 16 14 15 15 120 118 114 112 78 76 80 76 146 144 142 
74 74 84 76 15 17 15 18 116 110 118 110 72 74 76 80 142 142 144 
72 70 84 72 17 16 18 20 118 114 114 116 66 72 78 70 132 138 140 
70 70 86 70 16 17 17 22 120 116 116 106 64 66 66 72 145 144 138 
76 74 78 80 15 15 16 16 104 108 108 110 78 72 68 70 136 138 136 
74 72 84 82 18 14 16 18 108 110 106 118 80 72 78 76 138 142 136 
88 86 80 78 16 18 15 16 110 112 110 116 72 72 68 78 142 144 140 
88 80 82 80 16 16 14 16 102 110 108 108 74 72 76 72 143 142 142 
78 80 78 82 17 14 14 15 100 108 110 106 68 70 68 72 144 138 142 
78 80 80 80 18 18 17 18 102 110 108 110 64 66 68 70 140 138 142 
80 82 82 74 16 14 18 16 110 112 112 108 66 68 70 72 138 136 142 
82 82 80 72 15 16 17 16 112 118 118 112 76 74 72 74 142 140 142 
82 80 74 70 18 15 16 17 116 120 110 108 66 68 72 74 144 142 140 
88 86 72 82 17 14 15 18 108 114 116 110 64 70 66 68 150 148 146 
82 80 74 78 16 17 18 16 106 110 112 110 60 66 68 70 148 142 144 
78 78 70 76 17 15 15 15 110 110 112 108 62 66 68 66 136 138 140 
76 76 70 72 16 14 16 18 102 104 108 112 72 70 68 74 134 132 138 
78 80 74 70 15 18 17 17 104 100 106 108 66 60 68 68 128 132 130 
80 80 72 80 18 16 18 16 110 110 112 110 78 74 76 72 134 134 132 
86 84 86 82 16 17 14 17 120 116 116 120 78 68 70 68 128 132 130 
78 80 80 78 15 15 15 16 118 114 110 104 74 70 74 72 128 132 134 
82 82 80 80 18 14 14 17 116 110 114 108 76 76 74 76 126 130 128 
76 78 80 82 16 17 18 15 120 120 116 110 76 74 72 70 130 132 130 
82 80 74 82 17 16 17 15 114 116 112 102 70 72 72 74 145 144 142 
78 80 72 78 15 18 14 18 102 106 112 100 60 68 70 72 144 138 140 
86 84 70 76 15 16 16 17 108 110 108 102 78 76 74 76 132 136 132 
78 80 82 76 16 15 18 16 106 110 110 110 76 76 74 76 138 138 136 
74 76 78 80 17 18 17 16 110 114 116 112 72 76 68 70 146 144 140 
76 76 76 74 15 17 16 15 116 118 120 116 76 74 72 76 148 146 142 
80 80 72 70 15 16 15 14 118 116 114 108 74 72 72 74 142 140 140 
82 82 70 76 18 17 18 14 120 120 118 106 68 70 72 70 138 142 138 
 
 
  
 
 
71 CHITRA 23 20113 38+3 9 3 - 15 1 YES - - -   LSCS FA YES YES NO NO NO NO NO 8 9 
72 LAVANYA 26 19993 39+1 7 3 7 20 1 YES 240 25 10 275 VD   NO NO NO NO NO NO NO 8 9 
73 RAJAKUMARI 20 20223 39+2 10 7 9 25 1 YES 300 45 15 360 VD   NO NO NO NO NO NO NO 8 9 
74 REKHA 21 20309 38+3 10 8 8 NIL 2 NO 390 50 10 450 VD   NO NO NO NO NO NO NO 7 9 
75 GOMATHI 23 20354 37 7 3 7 10 1 YES 240 10 5 255 VD   NO NO NO NO NO NO NO 7 8 
76 SAROJINI 22 2789 39+4 7 3 6 10 1 NO 200 10 10 220 VD   YES NO NO NO NO NO NO 8 9 
77 USHA 24 2925 39+5 10 5 8 20 1 YES 240 35 10 285 VD   NO NO NO NO NO NO NO 8 9 
78 JAYANTHI 23 2935 38+4 7 2 7 10 1 YES 260 25 10 295 VD   NO NO NO NO NO NO NO 8 9 
79 VALLI 25 2901 39+2 8 3 4 20 1 YES 320 30 5 355 VD   NO NO NO NO NO NO NO 6 8 
80 SEETHA 22 2922 38+3 10 7 9 30 1 YES 320 40 10 370 VD   YES YES NO NO NO NO NO 8 9 
81 PANDI MEENA 20 2934 39+1 10 4 7 15 1 YES 240 20 15 275 VD   NO NO NO NO NO NO NO 8 9 
82 SUDHA 22 2981 39+2 10 4 7 15 1 YES 230 57 15 302 VACUUM   YES NO NO NO NO NO NO 8 9 
83 SUKANYA 21 3103 39+4 10 5 8 25 1 YES 320 35 10 365 VD   NO NO NO NO NO NO NO 8 9 
84 SUNITHA 18 3104 39+5 9 6 7 20 1 YES 240 20 10 270 VD   NO NO NO NO NO NO NO 8 9 
85 DHANA LAKSHMI 21 3147 38+6 7 3 7 18 1 NO 220 25 10 255 VD   NO NO NO NO NO NO NO 8 9 
86 GOWRI 21 3151 39+5 10 3 7 20 1 YES 320 45 10 375 VD   NO NO NO NO NO NO NO 8 9 
87 RANI 28 3307 39+6 10 9 9 NIL 1 YES 240 35 10 285 VD   NO NO NO NO NO NO NO 8 9 
88 BANU PRIYA 19 3296 40+1 10 6 - 25 2 YES - - -   LSCS FD NO NO NO NO NO NO NO 7 9 
89 MARI SELVI 21 3517 39+5 9 3 8 15 1 YES 200 35 10 245 VD   NO NO NO NO NO NO NO 8 9 
90 DIVYA 21 3563 39+3 10 4 6 20 1 YES 240 25 10 275 VD   NO NO NO NO NO NO NO 8 9 
91 LAKSHMI 23 3566 39+1 10 7 - 20 1 YES - - -   LSCS FD NO NO NO NO NO NO NO 8 9 
92 DHATCHAYANI 23 3626 39+6 9 3 6 18 1 YES 300 35 10 345 VD   YES YES NO NO NO NO NO 8 9 
93 TAMILSELVI 19 3683 39+4 10 3 4 14 1 NO 270 45 15 330 VD   NO NO NO NO NO NO NO 7 8 
94 MITHUNA 20 3755 39+3 10 4 8 15 1 YES 300 40 10 350 OUT-FOR   NO NO NO NO NO NO NO 8 9 
95 JOTHI 21 3973 39+1 10 3 8 10 1 NO 230 25 5 260 VD   NO NO YES NO NO NO NO 8 9 
96 SANGEETHA 22 4076 39+5 9 3 6 15 1 YES 250 30 10 290 VD   NO NO NO NO NO NO NO 8 9 
97 RAMYA 22 4155 39+3 6 3 4 20 1 YES 220 20 10 250 VD   YES NO NO NO NO NO NO 8 9 
98 SARASWATHI 27 4268 37+1 10 3 8 15 1 YES 260 20 5 285 VD   NO NO NO NO NO NO NO 8 9 
99 MAHESWARI 23 4359 39+3 7 2 7 18 1 NO 190 20 15 225 VD   NO NO NO NO NO NO NO 8 9 
100 REVATHI 20 4440 39+4 7 2 6 10 1 NO 160 12 10 182 VD   NO NO NO NO NO NO NO 8 9 
101 GAYATHIRI 19 4555 39+5 10 6 8 12 1 YES 200 25 10 235 VD   NO NO NO NO NO NO NO 8 9 
102 BHUVANESHWARI 24 4525 39+3 6 3 4 20 1 YES 200 10 8 218 VD   NO NO NO NO NO NO NO 8 9 
103 GANGAMMA 19 4543 40+3 10 3 6 15 1 YES 180 22 10 212 VD   NO NO NO NO NO NO NO 8 9 
104 RADHIKA 22 21528 39+3 10 3          - 17 1 YES 190 20 15 225 LSCS CPD NO NO NO NO NO NO NO 8 9 
105 KARTHIKA 19 21391 39+6 10 3 7 18 1 YES 220 30 5 255 OUT-FOR   NO NO NO NO NO NO NO 8 9 
106 INDUMATHI 18 21329 38+5 8 3 4 15 1 YES 260 30 8 298 VD   NO NO NO NO NO NO NO 8 9 
107 KARPAGAM 36 21537 39+3 9 6         - 10 1 YES          -          -          -   LSCS CPD NO NO NO NO NO NO NO 8 9 
108 MENAKA 19 21634 38+4 10 3 5 15 1 YES 270 50 10 330 VD   NO NO NO NO NO NO NO 7 8 
109 ANITHA 27 21654 38+3 9 3 7 20 1 YES 180 20 10 210 VD   NO NO NO NO NO NO NO 8 9 
110 NITHYA 21 21703 37+5 10 4 8 15 1 YES 220 20 10 250 VD   NO NO NO NO NO NO NO 8 9 
 
 
 
  
 
 
84 84 80 80 17 16 15 17 112 114 110 100 70 68 70 72 142 140 138 
86 84 82 86 16 15 16 18 118 114 116 102 74 72 70 68 138 142 142 
78 78 78 78 16 18 17 17 110 108 110 110 76 68 72 68 144 142 142 
88 86 80 86 15 16 18 16 120 116 118 112 78 72 70 72 136 140 142 
76 78 82 80 14 15 14 15 114 110 118 116 80 76 78 76 136 138 144 
72 70 82 84 14 18 16 18 102 108 106 110 72 74 70 72 140 140 138 
74 76 78 80 17 16 15 15 104 110 108 112 74 76 74 76 140 142 136 
72 72 76 80 14 17 14 16 110 112 116 114 72 66 68 68 142 140 138 
70 72 76 82 15 15 15 17 116 114 114 110 78 74 76 70 136 138 142 
82 80 80 80 17 15 14 18 110 108 106 108 76 70 76 72 142 142 138 
78 80 78 82 15 16 17 14 104 106 108 110 76 76 74 72 148 146 142 
76 78 74 80 14 17 15 16 108 110 106 114 78 76 78 70 144 142 138 
72 74 76 78 18 15 17 16 112 110 110 110 70 72 74 72 128 130 132 
70 72 80 78 17 15 16 15 118 114 120 110 76 76 74 78 130 132 128 
80 76 82 82 14 18 16 18 120 118 116 120 64 66 66 68 130 134 132 
82 80 84 84 16 17 15 16 116 114 114 108 68 64 66 70 128 132 130 
78 80 86 80 18 16 14 15 108 110 114 106 70 72 68 72 136 132 136 
80 82 78 78 17 16 14 18 106 110 112 110 76 74 76 78 142 138 142 
82 80 88 76 16 15 17 16 120 118 114 114 68 68 70 70 148 142 144 
82 82 76 82 15 14 16 18 120 116 116 116 64 66 66 66 142 144 142 
78 80 72 82 18 14 15 17 104 108 106 110 76 72 72 70 144 142 138 
76 78 74 78 15 17 14 17 106 110 110 104 68 72 70 72 136 140 140 
76 78 72 78 16 18 18 16 108 110 112 100 70 68 68 72 148 146 148 
80 82 70 80 17 17 18 15 110 114 116 118 72 70 72 70 134 138 132 
82 84 82 76 18 16 17 17 112 116 110 110 72 70 68 68 146 144 150 
78 80 78 80 14 15 15 16 120 116 118 112 76 72 74 74 138 142 144 
72 78 76 78 16 18 18 15 114 118 112 110 80 76 78 78 134 138 140 
74 76 72 72 15 15 15 14 114 120 118 112 72 74 74 72 144 140 142 
80 82 70 76 14 16 16 18 118 120 116 110 74 76 76 76 142 148 144 
82 82 80 78 15 17 17 18 118 120 116 120 78 76 78 78 134 128 132 
84 78 82 82 14 18 15 17 120 116 118 118 80 76 80 78 144 150 147 
76 78 78 84 17 14 14 15 108 112 110 116 74 76 72 76 142 144 143 
84 80 80 82 15 16 17 18 102 108 104 120 72 74 76 74 134 128 130 
72 76 86 74 16 15 15 15 100 104 104 114 68 70 72 70 128 132 132 
78 80 88 82 15 14 17 16 120 116 116 102 70 72 72 74 142 146 144 
72 78 78 78 15 15 18 17 116 114 112 108 80 76 78 76 140 142 144 
70 72 84 72 18 14 15 15 114 112 114 106 72 72 74 76 138 140 138 
78 76 80 74 17 17 16 14 118 118 116 110 74 72 80 80 136 142 132 
76 78 86 80 17 15 17 17 102 104 102 116 76 76 78 78 142 144 140 
80 82 78 82 16 16 15 15 108 110 110 118 80 78 76 78 130 138 134 
 
 
 
  
 
 
111 VANITHA MARY 30 21667 37+2 10 6 9 20 1 NO 240 22 10 272 VD   NO NO NO NO NO NO NO 8 9 
112 JEEVA 19 21271 37+3 10 3 8 18 1 NO 280 35 15 330 VD   YES YES NO NO NO NO NO 8 9 
113 ARUNA 19 21700 37+6 8 3 7 19 1 YES 270 40 12 322 VD   NO NO NO NO NO NO NO 8 9 
114 AMSA 19 21755 40+1 7 3 7 15 1 YES 200 30 10 240 VD   NO NO NO NO NO NO NO 8 9 
115 SUKANYA 19 21759 39+6 10 3 3 10 1 YES 170 22 10 202 VD   NO NO NO NO NO NO NO 8 9 
116 GNANAOLI 27 21720 40+1 10 4          - 25 1 YES          -          -            -   LSCS FD NO NO NO NO NO NO NO 8 9 
117 CAROLIN 24 21668 40+1 10 4          - 18 1 YES           -          -          -   LSCS CPD YES YES NO NO NO NO NO 8 9 
118 BHUVANESHWARI 28 21577 40+3 7 4 4 10 1 NO 200 30 7 237 VD   YES NO NO NO NO NO NO 8 9 
119 RAJESHWARI 26 21807 38+5 9 3 8 24 1 YES 205 20 8 233 VD   NO NO NO NO NO NO NO 6 7 
120 ESTHER 20 21859 39+1 9 3 3 19 1 YES 260 25 10 295 VD   NO NO NO NO NO NO NO 8 9 
121 REVATHI 21 21771 40+5 10 3 5 25 2 YES 320 30 15 365 VD   NO NO NO NO NO NO NO 8 9 
122 VEDHAVALLI 25 21836 38+3 10 3          - 14 1 YES         -             -          -   LSCS FA NO NO NO NO NO NO NO 8 9 
123 SHAMINI 24 21870 39+2 10 4 8 13 1 NO 180 25 13 218 VD   NO NO NO NO NO NO NO 8 9 
124 AMUDHA 27 21897 39+4 10 5 8 20 1 YES 240 70 15 325 OUT-FOR   NO NO NO NO NO NO NO 8 9 
125 GOWTHAMI 23 21909 39+3 10 9 9 NIL 1 YES 300 40 10 350 VD   NO NO NO NO NO NO NO 8 9 
126 SEETHA 23 21884 39+5 10 3 6 15 1 YES 260 55 5 320 VACUUM   NO NO NO NO NO NO NO 8 9 
127 BHUVANESHWARI 24 21961 38+3 7 3 3 20 1 YES 220 20 10 250 VD   NO NO NO NO NO NO NO 8 9 
128 DEVI 30 21984 38+2 10 9 9 NIL 1 YES 260 20 12 292 VD   NO NO NO NO NO NO NO 8 9 
129 SUKANYA 19 21972 39+2 10 3 8 25 1 YES 320 35 12 367 VD   YES YES NO NO NO NO NO 8 9 
130 CHITRA 26 21375 38+3 10 3          - 20 1 YES           - 
          
-          -   LSCS FD NO NO NO NO NO NO NO 8 9 
131 SARANYA 22 21841 39+2 10 4          - 15 1 NO          -          - 
          
-   LSCS FA YES NO NO NO NO NO NO 8 9 
132 MUNDIRA 20 22001 37+3 10 3 8 17 1 YES 280 25 10 315 VD   NO NO NO NO NO NO NO 7 9 
133 VIDHYA 19 22005 39 10 3 9 15 1 YES 300 40 18 358 VD   NO NO NO NO NO NO NO 8 9 
134 JAYANTHI 29 22035 39+5 10 3 9 13 1 YES 200 10 8 218 VD   NO NO NO NO NO NO NO 8 9 
135 SHANTHI 23 22114 39+1 10 9          - NIL 1 YES          -          -          -   LSCS FD YES YES NO NO NO NO NO 8 9 
136 MARIYAMMAL 21 22136 38+1 9 3 4 15 1 YES 260 20 10 290 VD   NO NO NO NO NO NO NO 8 9 
137 NANDHINI 20 22105 39+2 10 6 8 20 1 YES 270 22 10 302 VD   NO NO NO NO NO NO NO 8 9 
138 ANANDHI 25 22104 40+5 9 4          -  25 1 YES          - 
          
-          -   LSCS FD NO NO NO NO NO NO NO 8 9 
139 PAVALAKODI 20 22102 39 9 4 6 25 2 YES 360 45 6 411 OUT-FOR   YES YES NO NO NO NO NO 8 9 
140 DHANA LAKSHMI 25 22222 37+3 10 5 8 15 1 NO 200 20 10 230 VD   YES NO NO NO NO NO NO 8 9 
141 BABY 23 21221 38 9 5 9 20 1 NO 170 25 10 205 VD   NO NO NO NO NO NO NO 8 9 
142 NISHANTHINI 24 22122 39+1 9 5 - 18 1 YES - - -   LSCS CPD NO NO NO NO NO NO NO 8 9 
143 GEETHA PRIYA 24 22278 39+2 10 6 7 25 1 YES 220 22 10 252 VD   NO NO NO NO NO NO NO 8 9 
144 RAJESHWARI 30 22286 39+2 10 3 5 20 2 YES 380 50 10 440 OUT-FOR   NO NO NO NO NO NO NO 8 9 
145 MANJULA 30 22230 39+4 7 3 6 23 1 YES 320 35 18 373 VD   NO NO NO NO NO NO NO 8 9 
146 DURGA 21 22100 39+5 10 10 10 NIL 1 YES 260 20 10 290 VD   NO NO NO NO NO NO NO 7 8 
147 DIVYA BHARATHI 21 22108 39+4 7 3 5 14 1 YES 180 20 10 210 VD   NO NO NO NO NO NO NO 8 9 
148 KAVITHA 21 22251 38+6 9 3 3 15 1 YES 240 22 7 269 VD   NO NO NO NO NO NO NO 8 9 
149 UDHAYA 23 21622 37+2 9 9          - NIL 1 YES          -          -          -   LSCS FD NO NO NO NO NO NO NO 8 9 
150 REVATHI 25 22396 37+4 10 7          - 30 2 YES -          -          -   LSCS FA YES YES NO NO NO NO NO 8 9 
 
 
 
  
 
82 84 82 84 15 15 14 17 106 110 106 100 72 76 76 78 128 130 132 
80 82 84 76 17 15 17 18 110 114 110 110 68 70 70 72 124 128 130 
72 74 78 84 16 18 16 16 108 110 110 106 66 72 72 68 136 132 130 
76 74 80 72 19 17 22 17 120 116 120 110 76 74 76 76 138 132 132 
78 76 82 78 14 17 14 15 116 112 114 112 74 72 68 68 140 138 132 
80 82 80 72 18 16 15 14 114 112 106 114 68 70 68 72 142 140 142 
72 78 82 70 18 15 14 17 120 116 110 110 66 68 70 72 144 142 140 
74 82 84 78 17 19 19 15 118 120 108 108 64 66 66 68 136 138 142 
86 84 78 76 15 16 14 20 114 114 120 116 70 72 72 74 144 142 142 
78 80 74 80 18 20 17 17 116 120 116 114 72 74 74 76 138 140 142 
80 78 72 82 15 14 16 17 110 112 114 110 74 76 76 76 136 138 140 
78 80 76 80 16 18 14 17 102 108 118 118 80 78 76 76 134 136 138 
76 82 80 72 17 22 16 16 108 110 102 104 70 70 72 72 142 140 140 
78 82 72 76 15 17 15 15 104 100 108 110 72 70 68 70 128 132 132 
80 78 74 78 14 15 17 14 100 104 106 110 70 72 70 68 132 134 133 
82 76 86 80 17 18 22 17 116 110 110 112 80 78 78 76 138 132 136 
84 80 78 72 15 15 17 15 120 114 114 110 72 76 74 74 142 142 144 
88 80 80 74 17 16 15 14 116 114 110 116 74 74 72 74 148 144 142 
84 80 78 86 22 17 16 18 114 112 106 112 68 70 72 70 148 146 146 
76 82 76 78 15 15 14 16 118 116 110 112 70 74 76 74 142 140 142 
76 82 78 80 16 14 17 17 102 108 112 116 80 78 80 78 140 138 142 
78 80 80 78 17 17 16 15 108 110 114 120 80 76 72 74 138 132 138 
76 84 82 76 15 15 20 15 106 110 110 114 62 66 64 66 136 134 132 
80 78 84 78 14 17 15 18 110 112 108 120 68 66 68 68 142 140 138 
82 80 88 80 17 18 14 15 106 112 110 112 64 64 64 66 128 132 130 
84 82 84 82 15 15 17 16 110 114 114 108 66 64 66 64 126 128 132 
86 78 76 84 16 16 16 17 102 106 110 110 72 70 70 68 146 142 144 
82 80 76 88 17 17 17 15 104 108 108 118 78 76 74 74 146 144 142 
80 82 78 84 14 15 14 14 110 110 110 110 70 70 72 72 156 150 148 
78 82 76 76 15 14 15 17 120 114 118 108 72 70 72 72 148 148 142 
76 78 80 84 14 17 14 15 118 116 114 104 68 72 74 72 142 144 144 
74 76 82 86 16 15 16 17 116 110 116 100 76 78 80 76 134 138 142 
80 80 84 82 14 18 14 18 120 114 110 100 72 72 70 74 128 132 132 
86 80 86 80 17 22 17 15 114 112 112 112 68 70 72 72 136 134 134 
88 80 82 78 16 20 16 16 102 110 108 100 70 70 70 68 138 136 134 
78 82 80 76 14 20 14 17 108 110 112 110 72 74 70 72 142 142 140 
84 82 78 74 16 16 20 15 110 112 110 106 68 70 72 70 148 144 142 
80 80 76 80 20 15 17 15 116 112 112 110 60 66 68 64 142 142 138 
86 84 74 86 17 14 19 14 120 118 118 116 64 68 66 66 138 140 136 
78 78 80 88 14 17 17 17 108 116 114 114 76 70 76 74 140 136 138 
 
 
 
 
  
 
151 SHANMUGA PRIYA 22 22424 39+3 8 3 4 15 1 YES 300 38 10 348 VD   NO NO NO NO NO NO NO 8 9 
152 PRIYA 22 22484 39+4 10 6 8 14 2 YES 400 65 10 475 OUT-FOR   NO NO NO NO NO NO NO 8 9 
153 LAVANYA 26 21613 37+3 8 2 3 18 1 YES 220 22 5 247 VD   NO NO NO NO NO NO NO 8 9 
154 RAJESHWARI 20 22575 37+6 10 4 6 17 1 NO 180 15 10 205 VD   NO NO NO NO NO NO NO 8 9 
155 BHUVANESHWARI 21 22627 39+6 9 4 7 10 1 YES 390 60 15 465 LMC-FOR   NO NO NO NO NO NO NO 8 9 
156 DIVYA 23 22573 39+6 10 3 8 25 1 YES 230 20 5 255 VD   YES YES NO NO NO NO NO 8 9 
157 MUBEENA 24 22697 38+1 10 4 8 24 1 YES 370 50 10 430 OUT-FOR   NO NO YES NO NO NO NO 7 8 
158 ANJALI 21 22681 38+3 9 3 5 15 1 YES 240 13 10 263 VD   NO NO NO NO NO NO NO 8 9 
159 DIVYA 20 22738 39+6 10 4          - 25 1 YES          -          -          -   LSCS FD NO NO NO NO NO NO NO 8 9 
160 MANOHARI 20 22648 40+5 8 4 7 10 1 YES 340 45 8 393 OUT-FOR   NO NO NO NO NO NO NO 8 9 
161 JENIFER 24 22755 38+2 9 6 8 18 1 YES 295 19 10 324 VD   YES NO NO NO NO NO NO 8 9 
162 RAJA LAKSHMI 23 22094 39+3 9 4 8 18 1 YES 268 10 4 282 VD   NO NO NO NO NO NO NO 8 9 
163 SUKANYA 23 22796 39+2 8 2 6 15 1 NO 160 20 5 185 VD   NO NO NO NO NO NO NO 8 9 
164 DEVI 18 22837 39+2 8 3 5 17 1 NO 215 18 5 238 VD   YES NO NO NO NO NO NO 8 9 
165 PRIYA 21 22819 39+2 9 6 8 22 1 YES 220 25 10 255 VD   NO NO NO NO NO NO NO 8 9 
166 NAKATH FATHIMA 22 22757 39+5 7 3          - 18 1 NO          - 
          
-          -   LSCS CPD NO NO NO NO NO NO NO 8 9 
167 PAVITHRA 19 22855 40+1 10 3 3 18 2 YES 350 24 10 384 VD   NO NO NO NO NO NO NO 8 9 
168 GOMATHI 21 22889 39+1 9 3 6 17 1 NO 180 19 7 206 VD   NO NO NO NO NO NO NO 8 9 
169 NADHIYA 21 22890 38+3 9 3 7 15 1 YES 220 16 7 243 VD   YES NO NO NO NO NO NO 7 8 
170 SHARMILA 22 22744 39+2 9 5 6 NIL 1 YES 360 45 10 415 OUT-FOR   NO NO NO NO NO NO NO 8 9 
171 CHITRA 19 22662 38+1 10 4 4 22 1 NO 230 12 6 248 VD   NO NO NO NO NO NO NO 8 9 
172 FATHIMA 20 23038 38+6 9 3 5 22 2 YES 360 22 5 387 VD   NO NO NO NO NO NO NO 8 9 
173 VIJAYA LAKSHMI 19 23006 39+1 10 4 6 25 1 YES 220 18 10 248 VD   YES YES NO NO NO NO NO 8 9 
174 DEEPA 24 23085 38+2 8 3 5 18 1 YES 340 60 10 410 VACUUM   NO NO NO NO NO NO NO 8 9 
175 RAMYA 21 23066 39+1 6 4 6 15 1 NO 160 18 5 183 VD   NO NO NO NO NO NO NO 8 9 
176 JAYA ROSE MARY 26 23121 38+6 7 3          - 18 2 YES          -          -          -   LSCS FD YES NO NO NO NO NO NO 8 9 
177 MANJU 21 20367 39+2 9 4 6 17 1 YES 200 32 7 239 VD   NO NO NO NO NO NO NO 8 9 
178 GAYATHIRI 21 20453 38+6 10 7          - 28 2 YES          -          -          -   LSCS FD NO NO NO NO NO NO NO 8 9 
179 SANGEETHA 20 20460 39+3 8 2 6 20 1 YES 280 20 7 307 VD   NO NO NO NO NO NO NO 8 9 
180 
ANTONI 
VENNARASI 32 20538 39+1 6 2 6 20 1 YES 160 28 7 195 VD   YES YES NO NO NO NO NO 8 9 
181 LAKSHMI 22 20761 39+6 9 2 5 16 2 YES 320 27 8 355 VD   NO NO NO NO NO NO NO 8 9 
182 SHANTHA KUMARI 21 20830 39+2 10 4 8 17 1 NO 210 19 5 234 VD   NO NO NO NO NO NO NO 8 9 
183 BHARATHI 21 20615 37+1 9 4 9 20 1 YES 260 20 10 290 VD   YES NO NO NO NO NO NO 8 9 
184 CHANDRA 23 20888 40 8 3 4 18 1 YES 300 40 7 347 OUT-FOR   NO NO NO NO NO NO NO 7 9 
185 DURGA DEVI 23 20896 39+5 9 2 6 20 1 YES 280 30 5 315 VD   NO NO NO NO NO NO NO 6 9 
186 MANJULA 21 20881 38+3 9 2 4 23 1 NO 200 10 3 213 VD   NO NO NO NO NO NO NO 8 9 
187 KANAKA VALLI 24 20788 37+2 8 5 5 20 1 YES 200 10 3 213 VD   NO NO NO NO NO NO NO 8 9 
188 LAKSHMI 24 21101 39+3 9 4 6 18 1 YES 220 20 5 245 VD   NO NO NO NO NO NO NO 8 9 
189 NAVANEETHAM 26 20943 37+4 9 3 6 15 1 YES 180 20 5 205 VD   YES NO NO NO NO NO NO 8 9 
190 ABILASHA 23 20739 37+5 9 3 7 25 1 YES 270 21 7 298 VD   NO NO NO NO NO NO NO 8 9 
 
 
 
 
  
 
82 80 76 78 17 15 19 15 104 110 108 120 74 76 74 76 136 132 134 
84 82 80 84 15 14 20 16 118 116 104 116 60 60 62 66 142 138 136 
78 78 78 80 16 18 22 17 114 116 100 114 70 68 74 70 144 140 138 
80 84 72 86 14 16 16 14 120 118 100 118 72 68 70 72 146 138 144 
82 80 76 80 17 17 14 15 114 116 112 102 76 74 76 70 150 146 148 
80 82 78 76 16 15 17 22 114 112 100 108 68 70 72 74 146 144 146 
82 84 82 76 15 14 19 20 118 116 110 106 66 68 70 72 144 142 144 
84 88 84 80 18 17 20 19 116 114 106 112 60 66 68 70 148 142 146 
78 80 82 82 15 16 15 18 106 110 110 112 70 68 70 68 142 138 140 
74 84 74 84 17 15 17 17 102 108 110 112 72 70 68 70 140 136 142 
72 80 74 86 15 15 15 17 104 110 118 114 80 78 76 78 138 136 138 
76 80 76 82 19 14 17 19 106 110 116 102 76 74 76 80 132 130 140 
84 82 82 80 18 14 16 20 110 112 108 108 78 76 76 80 128 130 132 
78 80 78 78 16 16 15 22 118 112 110 110 80 78 76 80 142 138 138 
82 78 82 76 14 15 18 16 116 112 110 100 74 76 74 76 144 142 144 
82 86 84 74 18 16 14 20 120 118 114 104 74 72 76 74 140 138 140 
80 78 80 80 14 15 17 17 114 112 110 110 72 66 68 68 138 132 132 
84 80 78 82 16 14 15 19 118 118 102 114 68 68 70 72 132 136 134 
82 82 80 78 15 16 22 17 106 110 104 114 66 76 76 78 142 144 138 
78 78 82 80 14 15 16 19 106 108 114 112 76 78 78 80 138 138 142 
80 82 82 84 17 22 19 20 106 104 112 116 78 76 78 76 140 142 144 
74 76 78 84 15 20 19 22 108 100 118 108 80 78 76 74 142 144 142 
74 78 76 86 14 19 22 16 112 100 104 116 70 72 74 72 128 132 130 
72 76 80 76 18 18 19 14 116 112 106 118 72 70 72 74 150 148 146 
80 82 80 80 16 16 20 17 104 100 108 116 66 68 70 68 148 146 242 
82 78 80 82 17 14 15 15 118 110 110 112 68 70 72 74 144 142 146 
78 80 82 84 15 17 16 16 112 106 112 116 70 72 74 76 138 136 140 
80 82 82 86 14 15 17 17 118 110 120 114 68 70 72 74 132 134 138 
82 84 80 78 17 16 14 15 116 112 114 110 66 68 70 72 138 136 140 
86 86 84 84 16 15 15 14 114 114 115 108 76 74 72 76 142 144 142 
88 88 78 86 15 17 14 17 108 110 102 110 78 76 70 72 144 146 138 
78 80 80 86 15 15 16 15 104 108 108 108 80 78 74 76 144 142 140 
84 86 82 88 14 17 14 17 118 110 106 106 68 70 72 74 132 138 134 
80 82 78 78 20 16 17 16 116 112 110 110 70 72 74 76 138 143 140 
86 84 80 84 16 15 16 15 106 110 116 106 72 74 76 72 126 128 132 
78 80 82 80 15 18 14 15 108 112 110 110 66 66 68 70 130 132 132 
82 80 84 86 16 14 16 14 116 112 108 102 80 78 76 78 132 128 132 
84 82 86 78 15 17 15 14 100 112 118 104 74 72 68 68 138 136 130 
78 80 88 82 14 15 19 16 110 114 116 114 74 74 76 74 140 138 132 
80 82 80 84 16 18 14 15 108 116 112 112 78 76 74 76 144 142 144 
 
 
 
 
  
 
 
191 RAGEEMA 23 21230 37+6 9 3 5 15 1 YES 320 18 5 343 VD   NO NO NO NO NO NO NO 8 9 
192 THILAGAVATHI 23 21435 39+3 9 3 8 20 1 YES 180 13 5 198 VD   NO NO NO NO NO NO NO 8 9 
193 MAHALAKSHMI 28 21103 39+1 8 3 5 10 1 NO 200 15 5 220 VD   NO NO NO NO NO NO NO 8 9 
194 PREETHA 20 21590 39+5 10 3 5 20 2 YES 320 40 5 365 VD   YES YES NO NO NO NO NO 7 9 
195 VIJAYA LAKSHMI 19 21577 39+4 8 3 8 17 1 YES 220 15 5 240 VD   NO YES YES NO NO NO NO 8 9 
196 VARA LAKSHMI 25 21394 39+5 9 2 6 10 1 NO 220 15 8 243 VD   NO NO NO NO NO NO NO 8 9 
197 NISHA 22 21398 37+4 8 3 4 13 1 YES 240 25 7 272 VD   NO NO NO NO NO NO NO 8 9 
198 PREMA 24 21402 37+5 10 3 10 14 1 YES 260 28 8 296 VD   YES NO NO NO NO NO NO 8 9 
199 SATHYA 28 21410 39+2 9 3 8 10 1 YES 180 14 6 200 VD   NO NO NO NO NO NO NO 8 9 
200 CHINNA PONNU 21 21417 38+4 7 3 3 15 1 NO 150 8 5 163 VD   NO NO NO NO NO NO NO 8 8 
 
  
  
 
 
 
82 80 86 78 15 16 17 16 104 108 116 118 76 74 74 72 138 140 142 
80 82 82 80 16 17 15 15 104 108 116 104 72 76 76 76 136 138 136 
82 80 84 82 14 15 16 14 118 110 120 110 68 68 68 70 146 142 144 
84 86 80 80 16 14 14 16 114 110 114 110 70 74 72 72 144 140 142 
78 82 80 82 14 15 17 15 120 116 120 114 74 72 72 72 142 138 142 
74 76 82 84 15 15 16 16 118 114 112 110 74 76 76 74 138 136 140 
72 78 80 78 17 14 15 19 110 110 118 116 70 72 74 74 130 132 132 
76 78 82 74 15 14 18 20 100 104 108 110 66 70 68 68 136 128 134 
76 80 80 72 16 16 15 16 104 108 106 106 80 78 72 76 144 138 138 
72 78 82 76 14 15 17 20 116 108 110 108 80 76 76 78 142 144 138 
 
 
 
  
  
 
MASTER CHART – CONTROL GROUP 
S.NO NAME AGE IP.NO G.A 
DEGREES OF PAIN 
OXYTOCIN 
DURATION OF ACTIVE LABOUR TOTAL 
DURATION 
OF LABOUR 
MODE OF 
DELIVERY 
LSCS 
INDICATION 
ADVERSE EVENTS 
APGAR 
SCORE 
PULSE 
RATE 
BLOOD PRESSURE 
RESPIRATORY 
RATE 
FETAL 
HEART 
RATE NAUSEA VOMITTING DROWSINESS PALPITATION 
RESPIRATORY 
DISTRESS 
FETAL 
TACHYCARDIA 
STAGE 
1 
STAGE 
2 
STAGE 
1 
STAGE 
2 
STAGE 
3 
1 
MIN 
5 
MIN SYSTOLIC DIASTOLIC 
1 SARAL 23 18766 39+4 9 9 YES 220 30 5 255 VD   NO NO NO NO NO NO 8 9 80 110 68 16 138 
2 PRIYA 26 18704 39+6 9 - YES -           -           -           - LSCS FD NO NO NO NO NO NO 7 9 86 120 70 14 130 
3 SANGEETHA 20 18851 37+2 9 10 YES 300 49 7 356 VD   NO NO NO NO NO NO 8 9 82 114 64 16 144 
4 JENEFFER 23 18909 38+1 10 10 NO 420 40 10 470 VD   NO NO NO NO NO NO 8 9 74 116 68 18 142 
5 RAJALAKSHMI 21 18685 39+2 8 9 YES 180 10 10 200 VD   NO NO NO NO NO NO 8 9 88 120 80 14 144 
6 DURGA 21 18872 37+3 10 10 NO 360 31 17 408 VD   NO NO NO NO NO NO 8 9 84 108 74 18 134 
7 CHITRA 25 18927 38+4 10 9 YES 280 24 12 316 VD   NO NO NO NO NO NO 8 9 74 112 72 14 132 
8 MAHALAKSHMI 25 19034 40 9 9 YES 240 20 5 265 VD   NO NO NO NO NO NO 8 9 72 114 66 18 130 
9 SAMUNDESHWARI 21 19237 39+3 10 10 YES 375 65 10 450 OUT-FOR   NO NO NO NO NO NO 8 9 82 108 68 16 140 
10 DIVYA 20 19501 39+4 10 10 YES 180 15 10 205 VD   NO NO NO NO NO NO 8 9 84 100 70 18 148 
11 ANURADHA 21 19576 38+5 9 10 YES 360 30 10 400 VD   YES YES NO NO NO NO 8 9 84 120 78 15 152 
12 ARUNA  20 19686 39+2 10 10 NO 210 20 10 240 VD   NO NO NO NO NO NO 8 9 82 118 80 17 144 
13 SHARMILA 20 19768 39+2 8 10 YES 380 45 20 445 VD   NO NO NO NO NO NO 8 9 78 114 78 19 142 
14 GOMATHI 21 19864 38+3 9 10 YES 380 28 10 418 VD   NO NO NO NO NO NO 9 9 74 108 76 22 138 
15 LAKSHMI 24 19818 38+4 10 10 YES 260 22 10 292 VD   NO NO NO NO NO NO 8 9 80 110 68 21 136 
16 LATHA 21 19874 38+5 10 10 YES 400 38 18 456 VD   NO NO NO NO NO NO 7 8 84 120 70 18 136 
17 DURAISANI 20 19971 37+5 8 10 NO 420 40 10 470 VD   NO NO NO NO NO NO 8 9 80 114 72 16 144 
18 DHANA LAKSHMI 23 19892 39+2 9 9 YES 320 46 8 374 VD   NO NO NO NO NO NO 9 9 78 118 80 17 142 
19 THAEN MOZHI 23 19984 37+3 10 10 YES 240 30 10 280 VD   NO NO NO NO NO NO 8 9 74 110 74 18 142 
20 YESU MANI 22 20086 39 8 10 YES 290 26 5 321 VD   NO NO NO NO NO NO 8 9 78 120 68 16 140 
21 MAHALAKSHMI 20 20168 39+2 10 10 YES 280 20 10 310 VD   YES YES NO NO NO NO 8 9 80 108 70 17 140 
22 SARANYA 21 19795 39+2 8 9 YES 320 65 10 395 OUT-FOR   NO NO NO NO NO NO 8 9 82 104 70 18 138 
23 MANJULA 21 20031 39+5 8 8 NO 240 19 7 266 VD   NO NO NO NO NO NO 6 8 76 110 66 19 142 
24 RAMA LAKSHMI 25 20179 39+2 7 - YES   -           -            -            - LSCS FD NO NO NO NO NO NO 8 9 78 112 68 20 144 
25 VIDHYA LAKSHMI 22 2846 39+4 7 10 YES 200 26 8 234 VD   NO NO NO NO NO NO 8 9 82 118 78 22 134 
26 SANGEETHA 20 2784 39+2 10 10 YES 220 20 10 250 VD   NO NO NO NO NO NO 8 9 88 104 64 19 138 
27 RAMYA 23 2939 39+5 10 10 NO 270 21 17 308 VD   NO NO NO NO NO NO 8 9 78 106 64 15 142 
28 KANAKA 22 2937 38+2 10 10 YES 335 48 10 393 VD   NO NO NO NO NO NO 8 9 84 120 78 16 144 
29 GANGA BHAVANI 27 3023 38+6 10 10 YES 300 24 6 330 VD   NO NO NO NO NO NO 8 9 80 108 80 17 134 
30 PONNAMMAL 20 3071 39+5 10 10 YES 280 20 10 310 VD   NO NO NO NO NO NO 8 9 78 110 78 15 136 
31 KAVITHA 21 3109 39+6 8 9 YES 200 33 7 240 VD   NO NO NO NO NO NO 8 9 76 116 68 17 148 
32 GEETHA 22 3132 38+1 10 10 NO 260 15 10 285 VD   NO NO NO NO NO NO 8 9 74 118 68 18 146 
33 VIJAYA 22 3142 39+5 9 9 NO 230 20 10 260 VD   NO NO NO NO NO NO 8 9 78 108 70 17 128 
34 PARVATHI 23 3308 38+5 9 9 YES 260 15 5 280 VD   NO NO NO NO NO NO 8 9 80 110 72 15 130 
35 BOOMA DEVI 26 3381 37+3 9 9 YES 240 35 5 280 VD   NO NO NO NO NO NO 8 9 84 108 74 16 144 
36 MEENAKSHI 20 3255 39+2 10 10 YES 320 30 10 360 VD   NO NO NO NO NO NO 7 8 88 106 72 20 142 
37 SARTAJ 22 3489 39+1 10 10 YES 240 15 5 260 VD   NO NO NO NO NO NO 8 9 82 108 70 22 140 
38 VENNILA 26 3562 38+1 7 9 YES 300 40 20 360 OUT-FOR   NO NO NO NO NO NO 8 9 80 110 72 21 142 
39 RAJALAKSHMI 25 3674 38+3 9 10 YES 260 25 10 295 VD   NO NO NO NO NO NO 8 9 78 112 70 19 138 
40 DHATCHAYANI 21 3552 38+6 8 10 YES 310 25 10 345 VD   YES NO NO NO NO NO 8 9 76 116 74 18 136 
41 SAMUNDESHWARI 22 3812 39+2 10 10 YES 300 55 10 365 OUT-FOR   NO NO NO NO NO NO 8 9 74 114 72 17 142 
42 VASANTHI 25 3892 38+6 10 - YES  -             -           -        - LSCS CPD NO NO NO NO NO NO 8 9 86 110 78 15 140 
43 GANGA  20 4098 39+2 10 10 YES 220 17 13 250 VD   NO NO NO NO NO NO 8 9 80 100 68 19 138 
44 THAEN MOZHI 21 4092 38+3 7 9 NO 360 38 12 410 VD   NO NO NO NO NO NO 8 9 88 120 70 17 138 
45 NIRMALA DEVI 20 3846 37+6 10 10 YES 240 28 12 280 VD   NO NO NO NO NO NO 7 8 76 108 70 18 136 
46 ISHWARYA 19 4236 38+5 9 10 YES 300 19 13 332 VD   NO NO NO NO NO NO 8 9 80 110 70 19 132 
47 SARALA 23 4413 38+3 7 9 YES 320 30 10 360 VD   NO NO NO NO NO NO 8 9 86 116 72 20 128 
48 RAJESHWARI 29 4304 39+1 10 10 YES 200 20 10 230 VD   NO NO NO NO NO NO 8 9 84 118 74 21 152 
49 RADHIKA 19 4705 38+4 9 NIL NO 180 25 10 215 VD   NO NO NO NO NO NO 8 9 88 108 68 21 150 
50 NOORJAHAN 24 4569 38+4 10 10 NO 360 26 14 400 VD   NO NO NO NO NO NO 8 9 80 114 64 18 152 
 
 
  
 
 
51 MENAKA 26 21501 40 7 - YES -           -           -          - LSCS FD NO NO NO NO NO NO 7 8 78 108 62 17 148 
52 SUMITHRA 22 21391 38+6 9 - YES  -           -            -          - LSCS CPD NO NO NO NO NO NO 8 9 84 120 78 17 144 
53 SUMATHI 18 21535 38+4 10 9 YES 300 28 12 340 VD   NO NO NO NO NO NO 8 9 86 110 80 18 142 
54 ALAMELU 21 21420 39+4 10 10 NO 360 20 10 390 VD   YES YES NO NO NO NO 8 9 78 112 78 16 142 
55 MALAR 26 21661 39+4 8 10 YES 280 10 5 295 VD   NO NO NO NO NO NO 8 9 86 100 80 16 128 
56 SUDHA 22 21645 38+6 8 10 NO 340 30 10 380 VD   NO NO NO NO NO NO 8 9 82 108 68 17 126 
57 RADHIKA 19 20931 37+1 10 NIL YES 220 10 10 240 VD   NO NO NO NO NO NO 8 9 80 110 78 17 138 
58 JOTHI 21 21679 39+2 10 8 YES 270 30 15 315 VD   NO NO NO NO NO NO 8 9 80 108 72 15 142 
59 LAKSHMI 23 21737 40+5 10 - YES  -           -          -         - LSCS FA NO NO NO NO NO NO 8 9 82 120 74 19 144 
60 ANNA LAKSHMI 25 21745 38+1 7 - YES  -           -         -         - LSCS CPD NO NO NO NO NO NO 8 9 86 118 76 18 138 
61 ARUL SELVI 19 21752 40+1 10 10 NO 270 25 5 300 VD   NO NO NO NO NO NO 8 9 84 116 76 22 142 
62 USHA 30 20892 37+3 10 - YES  -           -          -          - LSCS CPD NO NO NO NO NO NO 8 9 86 108 68 19 136 
63 MENAKA 24 21754 39+5 10 - NO -            -         -          - LSCS FD NO NO NO NO NO NO 8 9 80 120 72 21 136 
64 SUJATHA 33 21778 39+4 10 10 YES 260 24 6 290 VD   NO NO NO NO NO NO 7 8 76 104 72 19 138 
65 HEMA LATHA 23 21834 38+6 8 - YES  -         -            -          - LSCS FA NO NO NO NO NO NO 8 9 80 108 68 18 140 
66 RAMYA 20 21811 39+1 10 10 NO 240 25 10 275 VD   NO NO NO NO NO NO 8 9 84 110 66 19 128 
67 JAYANTHI 21 21866 38+2 9 10 YES 310 17 5 332 VD   NO NO NO NO NO NO 8 9 82 112 64 16 138 
68 EZHIL ARASI 32 21883 37+2 10 - YES -          -           -          - LSCS CPD NO NO NO NO NO NO 8 9 76 118 74 15 148 
69 SUGANTHI 24 21875 37+6 9 9 YES 200 25 5 230 VD   NO NO NO NO NO NO 8 9 74 104 78 14 142 
70 UMA 22 21893 39+2 10 10 YES 320 60 10 390 VD   NO NO NO NO NO NO 8 9 72 120 78 18 144 
71 BHARATHI 20 21879 37+2 10 10 NO 400 25 5 430 VD   NO NO NO NO NO NO 6 8 78 112 68 19 146 
72 MANJULA 21 21921 38+4 9 9 YES 240 12 8 260 VD   NO NO NO NO NO NO 8 9 80 116 68 17 148 
73 SHALINI 25 21946 38+4 10 10 YES 280 30 7 317 VD   NO NO NO NO NO NO 8 9 72 100 64 16 144 
74 DAISY 23 21773 38+6 9 9 YES 220 25 10 255 VD   NO NO NO NO NO NO 8 9 74 120 78 19 148 
75 DEVIKA 22 21927 40+2 10 NIL NO 280 15 10 305 VD   NO NO NO NO NO NO 8 9 80 108 68 17 144 
76 RATHI KUMARI 25 21994 37+2 9 9 YES 290 13 5 308 VD   NO NO NO NO NO NO 8 9 76 116 68 16 148 
77 SARANYA 19 21995 39 10 - NO  -          -          -          - LSCS FD NO NO NO NO NO NO 8 9 78 110 66 19 136 
78 SHANTHI 26 22012 38+2 10 10 YES 200 10 5 215 VD   NO NO NO NO NO NO 7 8 72 118 64 16 128 
79 CHANDRA KALA 26 21711 39+4 10 10 YES 180 10 4 194 VD   NO NO NO NO NO NO 8 9 74 108 70 15 132 
80 
ANGALA 
PARAMESWARI 28 22023 37+2 8 - YES -         -          -         - LSCS FD NO NO NO NO NO NO 8 9 80 106 66 17 138 
81 TAMIL MOZHI 20 22070 40 10 10 YES 280 30 10 320 VD   NO NO NO NO NO NO 8 9 82 118 68 19 136 
82 JENEFFER 21 21958 39+1 10 10 NO 290 18 5 313 VD   NO NO NO NO NO NO 8 9 80 120 70 17 152 
83 RANJITHA 18 19807 38+2 9 NIL YES 280 15 5 300 VD   NO NO NO NO NO NO 8 9 84 118 72 18 148 
84 NOORJAHAN 21 22173 39+1 8 10 YES 270 15 5 290 VD   NO NO NO NO NO NO 8 9 80 108 74 16 142 
85 PRAMILA 21 22146 37+5 9 10 YES 320 65 10 395 OUT-FOR   NO NO NO NO NO NO 8 9 84 112 78 15 148 
86 KAVITHA 28 22171 38+3 10 10 YES 300 18 12 330 VD   NO NO NO NO NO NO 8 9 80 120 78 19 150 
87 VIJAYA LAKSHMI 24 22247 39+6 10 10 NO 320 25 5 350 VD   NO NO NO NO NO NO 7 8 78 108 70 15 148 
88 GAYATHIRI 19 22140 39 9 10 YES 200 15 5 220 VD   NO NO NO NO NO NO 8 9 80 110 68 17 142 
89 SIRISHA 30 22276 38+2 10 10 YES 320 45 10 375 VD   NO NO NO NO NO NO 8 9 82 118 64 17 148 
90 CHITRA 21 22083 40+2 10 10 YES 200 18 10 228 VD   NO NO NO NO NO NO 8 9 84 120 66 18 146 
91 SURYA 21 22277 40 10 10 NO 220 20 10 250 VD   NO NO NO NO NO NO 8 9 78 108 70 16 132 
92 DHANA LAKSHMI 20 22185 39+4 9 10 YES 190 10 5 205 VD   NO NO NO NO NO NO 8 9 80 114 68 16 130 
93 RAMYA 19 22347 39+3 10 10 YES 180 15 5 200 VD   NO NO NO NO NO NO 8 9 74 116 68 14 138 
94 BHAVANI 21 21804 39+2 9 9 YES 260 10 5 275 VD   NO NO NO NO NO NO 8 9 78 120 78 15 134 
95 SAMSUNEESHA 20 22041 39+2 10 - YES -          -         -          - LSCS CPD NO NO NO NO NO NO 8 9 82 118 70 15 138 
96 
UMA 
MAHAESHWARI 24 22309 40+2 10 - YES -          -         -          - LSCS FD NO NO NO NO NO NO 7 9 82 120 78 19 130 
97 
STELLA MARY 
HEART 24 22419 39+1 8 9 YES 240 15 10 265 VD   NO NO NO NO NO NO 7 8 78 108 70 17 144 
98 USHA 29 22366 38+2 9 - YES -          -         -           - LSCS FA NO NO NO NO NO NO 8 9 76 108 68 18 142 
99 HEPSIBA BEULA 22 22221 39 10 10 NO 260 10 10 280 VD   NO NO NO NO NO NO 8 9 80 110 68 16 148 
100 AYSHA BEEBI 21 22527 40+2 10 10 YES 280 60 10 350 OUT-FOR   YES YES NO NO NO NO 8 9 84 118 70 14 144 
101 KESARI 20 22443 40+1 10 10 YES 240 10 4 254 VD   NO NO NO NO NO NO 8 9 82 100 60 18 142 
102 PADMAVATHI 20 22541 39+4 9 NIL NO 320 15 10 345 VD   NO NO NO NO NO NO 8 9 76 108 70 15 138 
103 SALOMI 18 22649 39+5 8 - YES -         -          -          - LSCS FD NO NO NO NO NO NO 8 9 84 106 74 18 136 
104 LAKSHMI 26 22301 39+6 10 - YES -         -          -          - LSCS FD NO NO NO NO NO NO 8 9 80 116 76 16 138 
 
 
  
 
 
105 SASI REKHA 26 21609 38+1 8 9 YES 280 63 7 350 OUT-FOR   NO NO NO NO NO NO 8 9 78 114 68 15 140 
106 SUKANYA 21 22753 39+2 10 10 NO 270 33 7 310 VD   NO NO NO NO NO NO 8 9 82 120 70 18 142 
107 DEEPA 20 22663 38+1 8 8 YES 250 23 10 283 VD   NO NO NO NO NO NO 8 9 76 120 72 17 144 
108 UMA 22 22786 38+6 10 10 NO 240 10 5 255 VD   NO NO NO NO NO NO 8 9 80 116 74 17 146 
109 PARAMESHWARI 24 22805 38+4 8 10 YES 280 20 5 305 VD   NO NO NO NO NO NO 5 7 76 114 72 18 146 
110 NAFILA BEGUM 21 22798 40+5 8 10 YES 420 65 15 500 VACUUM   NO NO NO NO NO NO 8 9 82 108 68 15 132 
111 SELVI 20 22785 40 8 10 YES 420 60 10 490 OUT-FOR   NO NO NO NO NO NO 8 9 78 116 66 16 138 
112 SELVI 24 22810 39+1 10 10 YES 270 30 10 310 VD   NO NO NO NO NO NO 8 9 84 114 64 19 136 
113 DHANA LAKSHMI 24 22872 39+5 9 - YES 200 20 8 228 LSCS FD NO NO NO NO NO NO 7 8 78 110 72 16 142 
114 SUDHA 21 22821 39+1 10 10 YES 280 21 8 309 VD   NO NO NO NO NO NO 9 9 80 108 68 17 148 
115 RAJEE 24 22866 37+2 7 9 YES 225 29 7 261 VD   NO NO NO NO NO NO 8 9 82 110 66 17 138 
116 PREMALATHA 22 22919 38+2 9 - YES 220 20 8 248 LSCS   NO NO NO NO NO NO 8 9 82 108 64 18 148 
117 FARIDA 25 22938 39+2 10 10 NO 170 20 10 200 VD   NO NO NO NO NO NO 8 9 78 118 68 15 146 
118 RUBINI 20 22932 38+1 9 - YES -         -         -           - LSCS FD NO NO NO NO NO NO 8 9 78 108 72 18 146 
119 MANJULA 20 23046 40+1 8 - YES -         -         -          - LSCS FA NO NO NO NO NO NO 8 9 82 110 68 16 130 
120 KAVITHA 23 22904 39+2 9 10 YES 320 42 10 372 OUT-FOR   NO NO NO NO NO NO 8 9 80 118 78 20 148 
121 RADHA 26 23071 39+2 10 10 YES 200 60 10 270 VACUUM   NO NO NO NO NO NO 8 9 80 114 74 21 134 
122 SUMATHI 23 23002 38 8 10 YES 320 28 12 360 VD   NO NO NO NO NO NO 6 7 76 112 76 20 136 
123 SUDHA 23 20360 38+4 10 10 YES 250 38 12 300 VD   NO NO NO NO NO NO 8 9 72 112 68 18 144 
124 REKHA 21 20102 39+5 9 10 YES 300 44 18 362 VD   YES YES NO NO NO NO 8 9 82 120 78 19 142 
125 HEMALATHA 23 20335 38+6 10 - YES -         -         -          - LSCS CPD NO NO NO NO NO NO 8 9 78 112 80 21 138 
126 SHANTHI 24 20404 39+3 9 9 NO 210 21 7 238 VD   NO NO NO NO NO NO 8 9 80 104 78 18 144 
127 VITHEEYA 21 20293 37+2 9 9 NO 300 18 6 324 VD   NO NO NO NO NO NO 8 9 74 118 74 17 132 
128 SAVITHA 21 19968 37+5 10 9 YES 230 32 10 272 VD   NO NO NO NO NO NO 8 9 78 114 68 15 138 
129 SELVI 18 20489 38+2 9 9 YES 200 20 5 225 VD   NO NO NO NO NO NO 8 9 82 120 78 17 144 
130 KANKKADEVI 21 20683 37+2 10 10 YES 190 23 10 223 VD   NO NO NO NO NO NO 8 9 86 112 74 19 146 
131 SHANTHI 25 20723 39+1 10 9 YES 300 29 14 343 VD   YES YES NO NO NO NO 8 9 88 114 72 20 148 
132 GEETHA 24 20750 37+1 9 9 NO 230 22 6 258 VD   NO NO NO NO NO NO 8 9 76 118 74 21 144 
133 NITHYA 19 20792 39+1 7 10 YES 250 15 5 270 VD   NO NO NO NO NO NO 8 9 78 108 68 18 132 
134 IRUDHYA MARY 21 20845 38+1 8 8 YES 330 31 7 368 VD   NO NO NO NO NO NO 8 9 78 110 70 16 138 
135 KRISHNAVENI 30 20819 39+1 10 10 YES 270 25 10 305 VD   NO NO NO NO NO NO 9 9 82 110 74 19 142 
136 SRIMATHI 23 20672 40 8 8 YES 360 55 10 425 VACUUM   NO NO NO NO NO NO 8 9 82 120 78 18 138 
137 KUMUDHA 19 20882 39+2 10 10 NO 310 23 7 340 VD   NO NO NO NO NO NO 8 9 80 100 76 19 144 
138 REKHA 20 20833 39+2 9 9 YES 280 27 10 317 VD   NO NO NO NO NO NO 8 9 84 116 70 20 142 
139 GAYATHIRI 19 20946 39+1 10 10 YES 140 20 10 170 VD   NO NO NO NO NO NO 8 9 78 114 74 19 148 
140 MAHESHWARI 25 20790 38+6 9 - YES -         -        -        - LSCS FD NO NO NO NO NO NO 7 8 82 110 68 17 146 
141 INDIRA 21 20992 37+4 10 10 YES 400 50 10 460 VACUUM   NO NO NO NO NO NO 8 9 78 118 66 21 142 
142 GEETHA 19 21129 39+4 10 10 NO 260 20 10 290 VD   NO NO NO NO NO NO 8 9 78 116 64 15 138 
143 RADHA 23 21160 37+5 7 8 YES 250 18 7 275 VD   NO NO NO NO NO NO 8 9 78 108 66 18 142 
144 PRIYA 24 21209 39+1 9 10 YES 320 28 10 358 VD   NO NO NO NO NO NO 8 9 82 110 78 15 144 
145 AKILA 20 20956 39+6 8 10 YES 180 10 4 194 VD   NO NO NO NO NO NO 8 9 82 120 74 16 146 
146 JOTHI 24 21346 40+1 10 10 YES 270 22 8 300 VD   NO NO NO NO NO NO 8 9 80 112 70 19 136 
147 MEGHALA 24 19278 40+3 10 10 YES 200 23 10 233 VD   NO NO NO NO NO NO 8 9 82 116 72 17 138 
148 AMALA 28 21400 39+6 9 9 NO 190 20 10 220 VD   NO NO NO NO NO NO 6 8 84 118 74 14 132 
149 SANGEETHA 24 21376 40+5 10 9 YES 220 10 5 235 VD   NO NO NO NO NO NO 8 9 78 120 68 18 142 
150 KAVITHA 23 21491 39+8 7 9 YES 240 23 7 270 VD   NO NO NO NO NO NO 8 9 82 120 78 21 132 
151 GEETHA 23 21319 39+2 8 9 YES 200 20 10 230 VD   YES YES NO NO NO NO 6 8 86 114 70 22 146 
152 VASANTHA MANJU 23 21597 37+2 10 9 YES 290 35 7 332 VD   NO NO NO NO NO NO 8 9 84 118 72 19 132 
153 POONGODI 19 23052 38+5 10 - YES -          -      -         - LSCS FA NO NO NO NO NO NO 8 9 78 108 68 18 132 
154 PRABHA 28 23121 39+1 8 10 NO 280 25 10 315 VD   NO NO NO NO NO NO 8 9 80 106 66 14 138 
155 DIVYA 20 23036 37 10 10 NO 270 30 10 310 VD   NO NO NO NO NO NO 8 9 78 110 68 22 144 
156 SHOBANA 19 23048 37+6 10 9 YES 340 20 10 370 VD   NO NO NO NO NO NO 8 9 78 116 78 15 146 
157 AARTHI 27 23145 38 10 10 YES 320 20 7 347 VD   NO NO NO NO NO NO 8 9 80 100 70 18 142 
158 LATHA 25 23156 38+3 10 10 YES 360 30 10 400 OUT-FOR   NO NO NO NO NO NO 7 8 82 120 78 19 148 
 
 
  
 
159 CHITRA 24 23153 38+2 9 10 YES 280 55 15 350 VD   NO NO NO NO NO NO 8 9 80 118 74 20 146 
160 KIRTHIKA 22 23158 39+1 9 10 NO 200 20 10 230 VD   NO NO NO NO NO NO 8 9 82 108 68 16 144 
161 VANITHA 25 23211 39+5 9 9 YES 320 35 15 370 VD   NO NO NO NO NO NO 8 9 80 116 76 19 132 
162 VIDHYA 27 23225 40+5 10 10 YES 280 23 7 310 VD   NO NO NO NO NO NO 6 8 78 106 70 17 138 
163 VENNILA 20 23228 39+3 9 10 YES 240 24 10 274 VD   NO NO NO NO NO NO 8 9 80 104 70 15 148 
164 RAJAKUMARI 21 23249 39+1 9 9 YES 300 23 10 333 VD   NO NO NO NO NO NO 8 9 78 118 72 16 142 
165 AMUDHA 23 23259 39+2 7 8 YES 210 15 7 232 VD   NO NO NO NO NO NO 8 9 80 116 74 19 134 
166 PREMA 22 23267 38+1 9 9 YES 340 35 10 385 VACUUM   NO NO NO NO NO NO 8 9 82 120 76 17 136 
167 PRASANNA 23 23273 38+5 8 10 NO 280 25 5 310 VD   NO NO NO NO NO NO 8 9 84 118 78 18 142 
168 REKHA 19 23281 40 7 9 YES 300 21 7 328 VD   NO NO NO NO NO NO 8 9 78 116 78 16 138 
169 POORNIMA 20 23290 37+6 10 10 YES 200 15 5 220 VD   NO NO NO NO NO NO 8 9 80 114 64 19 142 
170 MYTHILI 22 23301 38+5 9 9 YES 190 20 8 218 VD   NO NO NO NO NO NO 8 9 78 118 68 16 132 
171 TAMILSELVI 21 23319 38+1 10 10 NO 280 38 10 328 VD   NO NO NO NO NO NO 8 9 82 120 78 17 136 
172 RANI 24 23328 39+3 10 10 YES 300 40 10 350 VD   NO NO NO NO NO NO 8 9 80 110 70 15 142 
173 MAHESHWARI 20 23308 39+1 9 10 YES 180 20 5 205 VD   YES YES NO NO NO NO 8 9 84 106 76 19 144 
174 KALAIVANI 19 23343 39+1 10 9 YES 210 25 10 245 VD   NO NO NO NO NO NO 7 8 84 102 74 15 138 
175 MUTHULAKSHMI 20 23352 38+5 9 - YES - - - - LSCS FD NO NO NO NO NO NO 6 8 88 100 68 17 132 
176 VASUKI 22 23348 38+1 8 10 YES 250 23 10 283 VD   NO NO NO NO NO NO 8 9 86 110 78 18 142 
177 MERCILIN 23 23339 38+5 10 10 YES 310 20 10 340 VD   NO NO NO NO NO NO 8 9 78 108 76 16 148 
178 ILAVARASI 21 23367 38+1 9 9 YES 380 20 7 407 OUT-FOR   NO NO NO NO NO NO 8 9 80 114 78 20 146 
179 SINDHUJA 20 23349 39+4 8 9 NO 240 30 10 280 VD   NO NO NO NO NO NO 8 9 82 116 74 18 136 
180 SASIKALA 25 23350 39+5 10 10 YES 290 23 17 230 VD   NO NO NO NO NO NO 8 9 86 120 78 19 136 
181 SOWMYA 29 23376 39+3 8 8 YES 150 10 5 165 VD   NO NO NO NO NO NO 8 9 78 110 80 17 142 
182 SHANTHI 27 23358 38+5 9 9 YES 290 15 10 315 VD   NO NO NO NO NO NO 8 9 84 108 78 14 148 
183 ZEENATH 19 23365 39 10 10 YES 260 20 10 290 VD   NO NO NO NO NO NO 8 9 80 118 76 18 142 
184 GNAMAMBAL 22 23373 39+1 8 10 NO 215 15 10 240 VD   NO NO NO NO NO NO 8 9 82 116 76 17 128 
185 MALATHI 23 23394 39+4 10 10 YES 290 30 10 330 VD   NO NO NO NO NO NO 8 9 78 110 70 18 150 
186 PARVATHAM 22 23402 38+4 10 10 YES 320 20 10 350 VD   NO NO NO NO NO NO 8 9 82 116 74 15 146 
187 LALITHA 20 23471 38 10 10 YES 240 28 12 280 VD   NO NO NO NO NO NO 8 9 80 118 72 14 144 
188 VENI 25 23492 38+1 7 10 YES 200 10 10 220 VD   NO NO NO NO NO NO 7 8 86 108 72 20 138 
189 SIVAKAMI 26 23520 38+6 8 - YES - - - - LSCS FD NO NO NO NO NO NO 7 8 82 108 78 14 134 
190 RADHIKA 20 23534 38+2 10 10 YES 300 25 10 335 OUT-FOR   NO NO NO NO NO NO 8 9 78 116 68 15 144 
191 KOUSALYA 24 23541 38+4 10 10 NO 180 25 10 215 VD   NO NO NO NO NO NO 8 9 84 114 66 19 152 
192 CHITRA 25 23452 39+1 8 8 YES 360 45 15 420 VD   NO NO NO NO NO NO 8 9 78 114 64 20 148 
193 DEVI RANI 27 23491 39+4 10 10 YES 280 30 10 320 VD   NO NO NO NO NO NO 8 9 82 120 74 18 144 
194 KAMALAVENI 22 23555 39 7 8 YES 320 30 10 360 VD   NO NO NO NO NO NO 8 9 80 110 68 16 136 
195 ROHINI 24 23561 40+2 9 9 YES 240 31 13 284 VD   YES YES NO NO NO NO 8 9 78 118 74 17 144 
196 SINDHUMATHI 23 23569 40+5 10 10 YES 220 30 15 265 VD   NO NO NO NO NO NO 8 9 80 114 72 16 148 
197 PADMAVATHI 23 23571 39+4 9 10 NO 270 24 8 302 VD   NO NO NO NO NO NO 8 9 84 112 76 15 132 
198 RAJAM 22 23578 39+5 10 10 YES 310 30 10 350 VD   NO NO NO NO NO NO 8 9 88 118 74 19 142 
199 KAVYA 20 23582 38+3 8 - YES - - -   LSCS FD NO NO NO NO NO NO 8 9 78 110 74 17 138 
200 KAYALVIZHI 21 23589 38+4 10 10 YES 320 20 5 345 VD   NO NO NO NO NO NO 8 9 80 108 76 16 144 
 
 
 
 
 
 
  
  
  
 
